<!DOCTYPE article
  PUBLIC "-//NLM//DTD Journal Archiving and Interchange DTD v3.0 20080202//EN" "archivearticle3.dtd">
<article xmlns:mml="http://www.w3.org/1998/Math/MathML" xmlns:xlink="http://www.w3.org/1999/xlink" article-type="research-article"><?properties open_access?><?DTDIdentifier.IdentifierValue -//Springer-Verlag//DTD A++ V2.4//EN?><?DTDIdentifier.IdentifierType public?><?SourceDTD.DTDName A++V2.4.dtd?><?SourceDTD.Version 2.4?><?ConverterInfo.XSLTName springer2nlmx2.xsl?><?ConverterInfo.Version 2?><front><journal-meta><journal-id journal-id-type="nlm-ta">AAPS J</journal-id><journal-title-group><journal-title>The AAPS Journal</journal-title></journal-title-group><issn pub-type="epub">1550-7416</issn><publisher><publisher-name>Springer US</publisher-name><publisher-loc>Boston</publisher-loc></publisher></journal-meta><article-meta><article-id pub-id-type="pmc">2751457</article-id><article-id pub-id-type="pmid">18446512</article-id><article-id pub-id-type="publisher-id">9012</article-id><article-id pub-id-type="doi">10.1208/s12248-008-9012-0</article-id><article-categories><subj-group subj-group-type="heading"><subject>Review Article</subject></subj-group></article-categories><title-group><article-title>Percutaneous Permeation Enhancement by Terpenes: Mechanistic View</article-title></title-group><contrib-group><contrib contrib-type="author"><name><surname>Sapra</surname><given-names>Bharti</given-names></name><xref ref-type="aff" rid="Aff1"/></contrib><contrib contrib-type="author"><name><surname>Jain</surname><given-names>Subheet</given-names></name><xref ref-type="aff" rid="Aff1"/></contrib><contrib contrib-type="author" corresp="yes"><name><surname>Tiwary</surname><given-names>A. K.</given-names></name><address><phone>+91-09417457385</phone><email>aktiwary2@rediffmail.com</email></address><xref ref-type="aff" rid="Aff1"/></contrib><aff id="Aff1">Department of Pharmaceutical Sciences and Drug Research, Punjabi University, Patiala, 147002 India </aff></contrib-group><pub-date pub-type="epub"><day>8</day><month>2</month><year>2008</year></pub-date><pub-date pub-type="pmc-release"><day>8</day><month>2</month><year>2008</year></pub-date><pub-date pub-type="collection"><month>3</month><year>2008</year></pub-date><volume>10</volume><issue>1</issue><fpage>120</fpage><lpage>132</lpage><history><date date-type="received"><day>6</day><month>11</month><year>2007</year></date><date date-type="accepted"><day>22</day><month>1</month><year>2008</year></date></history><permissions><copyright-statement>&#x000a9; American Association of Pharmaceutical Scientists 2008</copyright-statement></permissions><abstract xml:lang="en"><p>A popular approach for improving transdermal drug delivery involves the use of penetration enhancers (sorption promoters or accelerants) which penetrate into skin to reversibly reduce the barrier resistance. The potential mechanisms of action of penetration enhancers include disruption of intercellular lipid and/or keratin domains and tight junctions. This results in enhanced drug partitioning into tissue, altered thermodynamic activity/solubility of drug etc. Synthetic chemicals (solvents, azones, pyrrolidones, surfactants etc.) generally used for this purpose are rapidly losing their value in transdermal patches due to reports of their absorption into the systemic circulation and subsequent possible toxic effect upon long term application. Terpenes are included in the list of Generally Recognized As Safe (GRAS) substances and have low irritancy potential. Their mechanism of percutaneous permeation enhancement involves increasing the solubility of drugs in skin lipids, disruption of lipid/protein organization and/or extraction of skin micro constituents that are responsible for maintenance of barrier status. Hence, they appear to offer great promise for use in transdermal formulations. This article is aimed at reviewing the mechanisms responsible for percutaneous permeation enhancement activity of terpenes, which shall foster their rational use in transdermal formulations.</p></abstract><kwd-group><title>Key words</title><kwd>DSC</kwd><kwd>FTIR</kwd><kwd>percutaneous permeation enhancement</kwd><kwd>terpene</kwd><kwd>transdermal</kwd></kwd-group><custom-meta-group><custom-meta><meta-name>issue-copyright-statement</meta-name><meta-value>&#x000a9; American Association of Pharmaceutical Scientists 2008</meta-value></custom-meta></custom-meta-group></article-meta></front><body><sec id="Sec1"><title>INTRODUCTION</title><p>The skin acts as a barrier for diffusion of substances into the body. The main barrier for most substances is located in upper layer of skin, the stratum corneum (SC). The SC consists of keratin enriched dead cells, surrounded by crystalline intercellular lipid domains. These domains are continuous structures in the SC and are required for competent skin barrier function (<xref ref-type="bibr" rid="CR1">1</xref>). To achieve and to maintain effective therapeutic plasma drug concentrations, the barrier properties of skin sometimes have to be overcome to enable successful delivery. Both physical approaches (stratum corneum stripping, stratum corneum hydration, electrically assisted transdermal drug delivery) and chemical approaches (synthesis of lipophilic analogue, delipidization of SC, coadministration of penetration enhancers) have been investigated for accomplishing this goal. Extensive research during the past two decades has revealed considerable information on several classes of penetration enhancers, including surfactants (e.g. tween; <xref ref-type="bibr" rid="CR2">2</xref>), fatty acids/esters (e.g. oleic acid; <xref ref-type="bibr" rid="CR3">3</xref>), solvents (e.g. dimethylsulfoxide, ethanol; <xref ref-type="bibr" rid="CR4">4</xref>) and terpenes (e.g. limonene; <xref ref-type="bibr" rid="CR5">5</xref>). Despite their fairly satisfactory performance in enhancing the permeation of drug molecule across the skin, chemical enhancers are viewed with suspicion in transdermal formulations due to their irritancy potential when employed at concentrations necessary for achieving useful levels of penetration enhancement (<xref ref-type="bibr" rid="CR6">6</xref>).</p><p>Efforts have been directed at identifying safe and effective enhancers from both natural products and synthetic chemicals. In particular, terpenes from natural sources and laboratory designed terpenoids have attracted great interest (<xref ref-type="bibr" rid="CR7">7</xref>&#x02013;<xref ref-type="bibr" rid="CR9">9</xref>). Terpenes are generally considered to be less toxic with low irritancy potential compared to surfactants and other synthetic skin penetration enhancers. Further, quite a few terpenes are included in the list of Generally Recognized As Safe (GRAS) agents issued by US FDA (<xref ref-type="bibr" rid="CR9">9</xref>,<xref ref-type="bibr" rid="CR10">10</xref>).</p><p>Terpenes can increase skin permeation by one or more of the mechanisms (Table <xref rid="Tab1" ref-type="table">I</xref>): interacting with SC lipids and/or keratin, and increasing the solubility of drug into SC lipids (<xref ref-type="bibr" rid="CR9">9</xref>). However, the interaction of terpenes with SC in presence of various solvents may not be similar due to differences in the physico-chemical properties of these solvents and their interactions with SC. These interactions can be determined by instrumental methods, such as, differential scanning calorimetry (DSC) and Fourier transform infrared spectroscopy (FTIR). Table <xref rid="Tab2" ref-type="table">II</xref> summarizes the effect of several terpenes on thermotropic behaviour of skin. DSC thermograms of skin treated with permeation enhancers can be evaluated by comparing the endotherms and exotherms for mean transition temperature (<italic>T</italic><sub>m</sub>), cooperativity and their enthalpies (&#x00394;<italic>H</italic>). Shifting of <italic>T</italic><sub>m</sub> of both lipid transitions T2 and T3 to lower temperature is generally ascribed to the disruption of lipid bilayer while the reduction in &#x00394;<italic>H</italic> is associated with fluidization of lipid bilayers of SC (<xref ref-type="bibr" rid="CR28">28</xref>,<xref ref-type="bibr" rid="CR29">29</xref>). Table <xref rid="Tab3" ref-type="table">III</xref> summarizes the effects of several terpenes on the FTIR spectrum of skin. FTIR analysis provides information about the molecular and conformational changes in SC lipids and proteins. The asymmetric and symmetric C&#x02013;H vibrations obtained at 2,920 and 2,850&#x000a0;cm<sup>&#x02212;1</sup>, respectively, have been ascribed to hydrocarbon lipid chains of SC. The height and area of these two peaks have been found to be proportional to the amount of lipids present in SC (<xref ref-type="bibr" rid="CR32">32</xref>). The C=O stretching vibration of lipid polar head groups produce a band near 1,740&#x000a0;cm<sup>&#x02212;1</sup>. In addition, strong amide and water absorbance bands are found in region of 1,500&#x02013;1,700 and 3,000&#x02013;3,600&#x000a0;cm<sup>&#x02212;1</sup>, respectively. The bands at 1,650 and 1,550&#x000a0;cm<sup>&#x02212;1</sup> have been suggested to arise from amide I and amide II stretching vibrations, respectively, of the SC proteins. The frequencies of these two bands, especially amide I band, are sensitive and shift to higher or lower frequencies according to the change in protein conformation (<xref ref-type="bibr" rid="CR33">33</xref>). Therefore, both methods provide independent but complementary data about the interaction of terpenes with SC in the presence of different solvents.
<table-wrap id="Tab1"><label>Table&#x000a0;I</label><caption><p>Influence of Terpene Treatment on Percutaneous Permeation Enhancement of Drugs</p></caption><table frame="hsides" rules="groups"><thead><tr><th>Terpene</th><th>Vehicle</th><th>Skin</th><th>Study Duration (h)</th><th>Drug</th><th>ER</th><th>Proposed Mechanism</th><th>Reference</th></tr></thead><tbody><tr><td rowspan="6"><italic>d</italic>-limonene</td><td>Neat liquid</td><td>&#x02013;</td><td>12</td><td>5-FU</td><td>4</td><td>Lipid disruption</td><td>(<xref ref-type="bibr" rid="CR11">11</xref>)</td></tr><tr><td>PG: Water (80:20)</td><td>Human</td><td>&#x000a0;</td><td>5-FU</td><td>4.3</td><td>Freezing point depression</td><td>(<xref ref-type="bibr" rid="CR12">12</xref>)</td></tr><tr><td>Hydroxy propyl cellulose gel</td><td>Hairless mice</td><td>24</td><td>Nicardipine HCl</td><td>60</td><td>&#x02013;</td><td>(<xref ref-type="bibr" rid="CR13">13</xref>)</td></tr><tr><td>Hydroxy propyl cellulose gel</td><td>Hairless mice</td><td>24</td><td>CPZ</td><td>6.6</td><td>&#x02013;</td><td>(<xref ref-type="bibr" rid="CR13">13</xref>)</td></tr><tr><td>Hydroxy propyl cellulose gel</td><td>Hairless mice</td><td>24</td><td>Hydrocortisone</td><td>28</td><td>&#x02013;</td><td>(<xref ref-type="bibr" rid="CR13">13</xref>)</td></tr><tr><td>PG</td><td>Human</td><td>60</td><td>Haloperidol</td><td>26.52</td><td>&#x02013;</td><td>(<xref ref-type="bibr" rid="CR14">14</xref>)</td></tr><tr><td rowspan="4">Limonene oxide</td><td>Ethanol (50% <italic>v</italic>/<italic>v</italic>)</td><td>Human</td><td>48</td><td>Haloperidol</td><td>14.3</td><td>Lipid disruption and extraction</td><td>(<xref ref-type="bibr" rid="CR17">17</xref>)</td></tr><tr><td>PG</td><td>Human</td><td>48</td><td>Haloperidol</td><td>9.18</td><td>Lipid disruption</td><td>(<xref ref-type="bibr" rid="CR17">17</xref>)</td></tr><tr><td>Ethanol (50% <italic>v</italic>/<italic>v</italic>)</td><td>Human</td><td>48</td><td>Haloperidol</td><td>40.25</td><td>Lipid disruption, extraction and fluidization</td><td>(<xref ref-type="bibr" rid="CR17">17</xref>)</td></tr><tr><td>PG</td><td>Human</td><td>48</td><td>Haloperidol</td><td>10.4</td><td>Lipid disruption</td><td>(<xref ref-type="bibr" rid="CR17">17</xref>)</td></tr><tr><td rowspan="6">1,8-cineole</td><td>Neat liquid</td><td>&#x02013;</td><td>12</td><td>5-FU</td><td>95.3</td><td>Lipid disruption</td><td>(<xref ref-type="bibr" rid="CR11">11</xref>)</td></tr><tr><td>PG:water (80:20)</td><td>Human</td><td>&#x000a0;</td><td>5-FU</td><td>24</td><td>Lipid disruption</td><td>(<xref ref-type="bibr" rid="CR12">12</xref>)</td></tr><tr><td>Ethanol (47% <italic>v</italic>/<italic>v</italic>)</td><td>Human</td><td>40</td><td>Thyrotropin releasing hormone</td><td>3.39</td><td>Modification of lipid bilayer structure with terpene and lipid extraction with ethanol</td><td>(<xref ref-type="bibr" rid="CR18">18</xref>)</td></tr><tr><td>Ethanol (66.6% <italic>v</italic>/<italic>v</italic>)</td><td>Rat</td><td>24</td><td>Zidovudine</td><td>55.8</td><td>Intercellular lipoidal pathway</td><td>(<xref ref-type="bibr" rid="CR19">19</xref>)</td></tr><tr><td>Ethanol (66.6% <italic>v</italic>/<italic>v</italic>)</td><td>Human</td><td>24</td><td>Zidovudine</td><td>18</td><td>Lipid fluidization</td><td>(<xref ref-type="bibr" rid="CR20">20</xref>)</td></tr><tr><td>PG</td><td>Human</td><td>60</td><td>Haloperidol</td><td>6.88</td><td>&#x02013;</td><td>(<xref ref-type="bibr" rid="CR14">14</xref>)</td></tr><tr><td rowspan="5">Nerolidol</td><td>Neat liquid</td><td>&#x02013;</td><td>12</td><td>5-FU</td><td>25</td><td>Lipid disruption</td><td>(<xref ref-type="bibr" rid="CR11">11</xref>)</td></tr><tr><td>PG:water (80:20)</td><td>Human</td><td>&#x000a0;</td><td>5-FU</td><td>18</td><td>Lipid disruption</td><td>(<xref ref-type="bibr" rid="CR12">12</xref>)</td></tr><tr><td>Hydroxy propyl cellulose gel</td><td>Hairless mice</td><td>24</td><td>Nicardipine HCl</td><td>134.8</td><td>&#x02013;</td><td>(<xref ref-type="bibr" rid="CR13">13</xref>)</td></tr><tr><td>Hydroxy propyl cellulose gel</td><td>Hairless mice</td><td>24</td><td>CPZ</td><td>7.5</td><td>&#x02013;</td><td>(<xref ref-type="bibr" rid="CR13">13</xref>)</td></tr><tr><td>Hydroxy propyl cellulose gel</td><td>Hairless mice</td><td>24</td><td>Hydrocortisone</td><td>32.7</td><td>&#x02013;</td><td>(<xref ref-type="bibr" rid="CR13">13</xref>)</td></tr><tr><td rowspan="4">Menthone</td><td>Neat liquid</td><td>&#x02013;</td><td>12</td><td>5-FU</td><td>42</td><td>Lipid disruption</td><td>(<xref ref-type="bibr" rid="CR11">11</xref>)</td></tr><tr><td>PG:water (80:20)</td><td>Human</td><td>&#x000a0;</td><td>5-FU</td><td>20</td><td>Lipid disruption</td><td>(<xref ref-type="bibr" rid="CR12">12</xref>)</td></tr><tr><td>Ethanol (47% <italic>v</italic>/<italic>v</italic>)</td><td>Human</td><td>40</td><td>Thyrotropin releasing hormone</td><td>3.33</td><td>Modification of lipid bilayer structure with terpene and lipid extraction with ethanol</td><td>(<xref ref-type="bibr" rid="CR18">18</xref>)</td></tr><tr><td>Ethanol (66.6% <italic>v</italic>/<italic>v</italic>)</td><td>Rat</td><td>24</td><td>Zidovudine</td><td>46.09</td><td>Through intercellular lipoidal pathway</td><td>(<xref ref-type="bibr" rid="CR19">19</xref>)</td></tr><tr><td rowspan="7">Menthol </td><td>Ethanol (70% <italic>v</italic>/<italic>v</italic>)</td><td>&#x02013;</td><td>24</td><td>Nicardipine HCl</td><td>7.12</td><td>Lipid extraction</td><td>(<xref ref-type="bibr" rid="CR21">21</xref>)</td></tr><tr><td>IPA/PG/water (30:30:40)</td><td>Rat</td><td>24</td><td>Zidovudine</td><td>87</td><td>Increased diffusion of drug in SC</td><td>(<xref ref-type="bibr" rid="CR22">22</xref>)</td></tr><tr><td>Ethanol (66.6% <italic>v</italic>/<italic>v</italic>)</td><td>Rat</td><td>24</td><td>Zidovudine</td><td>49.97</td><td>Through intercellular lipoidal pathway</td><td>(<xref ref-type="bibr" rid="CR19">19</xref>)</td></tr><tr><td>Hydroxy propyl cellulose gel</td><td>Rat</td><td>24</td><td>Nicardipine HCl</td><td>7.12</td><td>SC lipid extraction</td><td>(<xref ref-type="bibr" rid="CR21">21</xref>)</td></tr><tr><td>Poloxamer 407 gel</td><td>Mice</td><td>24</td><td>Ibuprofen</td><td>2.08</td><td><bold>&#x02013;</bold></td><td>(<xref ref-type="bibr" rid="CR15">15</xref>)</td></tr><tr><td>Poloxamer 407 liquid formulation</td><td>Mice</td><td>24</td><td>Ibuprofen</td><td>&#x000a0;</td><td>&#x02013;</td><td>(<xref ref-type="bibr" rid="CR15">15</xref>)</td></tr><tr><td>Carboxy methyl cellulose sodium gel</td><td>Rat</td><td>24</td><td>Etodolac</td><td>1.06</td><td>Increased hydrophilicity of SC resulted in lesser permeation of lipophilic drug.</td><td>(<xref ref-type="bibr" rid="CR16">16</xref>)</td></tr><tr><td rowspan="5">Carvone</td><td>Ethanol (66.6% <italic>v</italic>/<italic>v</italic>)</td><td>Human</td><td>24</td><td>Zidovudine</td><td>11.4</td><td>Lipid fluidization</td><td>(<xref ref-type="bibr" rid="CR20">20</xref>)</td></tr><tr><td>Ethanol (70% <italic>v</italic>/<italic>v</italic>)</td><td>&#x000a0;</td><td>24</td><td>Nicardipine HCl</td><td>7.89</td><td>Lipid extraction</td><td>(<xref ref-type="bibr" rid="CR23">23</xref>)</td></tr><tr><td>Ethanol (60% <italic>v</italic>/<italic>v</italic>)</td><td>Rat</td><td>24</td><td>Nimodipine</td><td>4.56</td><td>Lipid bilayer disruption and partial extraction of SC lipids</td><td>(<xref ref-type="bibr" rid="CR24">24</xref>)</td></tr><tr><td>Ethanol (66.6% <italic>v</italic>/<italic>v</italic>)</td><td>Rat</td><td>24</td><td>Zidovudine</td><td>32.02</td><td>Through intercellular lipoidal pathway</td><td>(<xref ref-type="bibr" rid="CR19">19</xref>)</td></tr><tr><td>Ethanol:glycerine:PB (60:10:30)</td><td>Rat</td><td>24</td><td>Diclofenac sodium</td><td>&#x000a0;</td><td>Increase in drug diffusion and partitioning into skin</td><td>(<xref ref-type="bibr" rid="CR25">25</xref>)</td></tr><tr><td rowspan="4">Carvacrol</td><td>Ethanol (50% <italic>v</italic>/<italic>v</italic>)</td><td>&#x000a0;</td><td>48</td><td>Haloperidol</td><td>12.1</td><td>Lipid extraction and disruption</td><td>(<xref ref-type="bibr" rid="CR26">26</xref>)</td></tr><tr><td>IPA:water (60:40)</td><td>Rat</td><td>24</td><td>Zidovudine</td><td>8.52</td><td>Increased diffusion of drug in SC</td><td>(<xref ref-type="bibr" rid="CR22">22</xref>)</td></tr><tr><td>PG</td><td>&#x000a0;</td><td>48</td><td>Haloperidol</td><td>4.4</td><td>Lipid extraction and disruption</td><td>(<xref ref-type="bibr" rid="CR27">27</xref>)</td></tr><tr><td>Carboxy methyl cellulose sodium gel</td><td>Rat</td><td>24</td><td>Etodolac</td><td>0.02</td><td>Increased hydrophilicity of SC resulted in lesser permeation of lipophilic drug.</td><td>(<xref ref-type="bibr" rid="CR15">15</xref>)</td></tr><tr><td rowspan="4">Linalool</td><td>Ethanol (50% <italic>v</italic>/<italic>v</italic>)</td><td>&#x000a0;</td><td>48</td><td>Haloperidol</td><td>6.33</td><td>Lipid extraction and disruption</td><td>(<xref ref-type="bibr" rid="CR26">26</xref>)</td></tr><tr><td>IPA:water (60:40)</td><td>Rat</td><td>24</td><td>Zidovudine</td><td>24.6</td><td>Increased diffusion of drug in SC</td><td>(<xref ref-type="bibr" rid="CR22">22</xref>)</td></tr><tr><td>PG</td><td>&#x000a0;</td><td>48</td><td>Haloperidol</td><td>85.7</td><td>Lipid extraction and disruption</td><td>(<xref ref-type="bibr" rid="CR27">27</xref>)</td></tr><tr><td>PG</td><td>Human</td><td>60</td><td>Haloperidol</td><td>8.05</td><td>&#x02013;</td><td>(<xref ref-type="bibr" rid="CR14">14</xref>)</td></tr><tr><td rowspan="3">&#x003b1;-terpineol</td><td>Ethanol (50% <italic>v</italic>/<italic>v</italic>)</td><td>&#x000a0;</td><td>48</td><td>Haloperidol</td><td>8.86</td><td>Lipid extraction and disruption</td><td>(<xref ref-type="bibr" rid="CR26">26</xref>)</td></tr><tr><td>PG</td><td>&#x000a0;</td><td>48</td><td>Haloperidol</td><td>1.73</td><td>Lipid extraction and disruption</td><td>(<xref ref-type="bibr" rid="CR27">27</xref>)</td></tr><tr><td>Ethanol (66.6% <italic>v</italic>/<italic>v</italic>)</td><td>Rat</td><td>24</td><td>Zidovudine</td><td>44.55</td><td>Through intercellular lipoidal pathway</td><td>(<xref ref-type="bibr" rid="CR19">19</xref>)</td></tr><tr><td rowspan="3">Fenchone</td><td>Hydroxypropyl cellulose gel</td><td>Hairless mice</td><td>24</td><td>Nicardipine HCl</td><td>17.9</td><td>&#x02013;</td><td>(<xref ref-type="bibr" rid="CR13">13</xref>)</td></tr><tr><td>Hydroxy propyl cellulose gel</td><td>Hairless mice</td><td>24</td><td>CPZ</td><td>1.5</td><td>&#x02013;</td><td>(<xref ref-type="bibr" rid="CR13">13</xref>)</td></tr><tr><td>Hydroxy propyl cellulose gel</td><td>Hairless mice</td><td>24</td><td>Hydrocortisone</td><td>7.8</td><td>&#x02013;</td><td>(<xref ref-type="bibr" rid="CR13">13</xref>)</td></tr><tr><td rowspan="3">Thymol</td><td>Hydroxypropyl cellulose gel</td><td>Hairless mice</td><td>24</td><td>Nicardipine HCl</td><td>18.2</td><td>&#x02013;</td><td>(<xref ref-type="bibr" rid="CR13">13</xref>)</td></tr><tr><td>Hydroxy propyl cellulose gel</td><td>Hairless mice</td><td>24</td><td>CPZ</td><td>4.2</td><td>&#x02013;</td><td>(<xref ref-type="bibr" rid="CR13">13</xref>)</td></tr><tr><td>Hydroxy propyl cellulose gel</td><td>Hairless mice</td><td>24</td><td>Hydrocortisone</td><td>10.5</td><td>&#x02013;</td><td>(<xref ref-type="bibr" rid="CR13">13</xref>)</td></tr><tr><td rowspan="4">Pinene oxide</td><td>Ethanol (50% <italic>v</italic>/<italic>v</italic>)</td><td>&#x000a0;</td><td>48</td><td>Haloperidol</td><td>14.3</td><td>Lipid disruption and extraction</td><td>(<xref ref-type="bibr" rid="CR17">17</xref>)</td></tr><tr><td>PG</td><td>&#x000a0;</td><td>48</td><td>Haloperidol</td><td>9.18</td><td>Lipid disruption and extraction</td><td>(<xref ref-type="bibr" rid="CR17">17</xref>)</td></tr><tr><td>Ethanol (50% <italic>v</italic>/<italic>v</italic>)</td><td>Human</td><td>48</td><td>Haloperidol</td><td>24.23</td><td>Lipid fluidization within the ordered SC environment</td><td>(<xref ref-type="bibr" rid="CR17">17</xref>)</td></tr><tr><td>PG</td><td>Human</td><td>48</td><td>Haloperidol</td><td>6.53</td><td>Lipid fluidization within the ordered SC environment</td><td>(<xref ref-type="bibr" rid="CR17">17</xref>)</td></tr><tr><td>Pulegeon</td><td>Ethanol (66.6% <italic>v</italic>/<italic>v</italic>)</td><td>Rat</td><td>24</td><td>Zidovudine</td><td>45.34</td><td>Through intercellular lipoidal pathway</td><td>(<xref ref-type="bibr" rid="CR19">19</xref>)</td></tr></tbody></table></table-wrap><table-wrap id="Tab2"><label>Table&#x000a0;II</label><caption><p>Influence of Terpene Treatment on Thermotropic Attributes of Drugs</p></caption><table frame="hsides" rules="groups"><thead><tr><th rowspan="3">Terpene</th><th rowspan="3">Vehicle</th><th rowspan="3">Drug</th><th rowspan="3"><italic>T</italic><sub>m</sub> (&#x000b0;C)</th><th colspan="4">Thermotropic Attributes</th><th rowspan="3">Proposed Mechanism</th><th rowspan="3">Ref.</th></tr><tr><th>T2</th><th colspan="2">T3</th><th>T4</th></tr><tr><th>% &#x00394;<italic>H</italic> (J/g)</th><th><italic>T</italic><sub>m</sub> (&#x000b0;C)</th><th>% &#x00394;<italic>H</italic> (J/g)</th><th><italic>T</italic><sub>m</sub> (&#x000b0;C)</th></tr></thead><tbody><tr><td rowspan="4"><italic>d</italic>-limonene</td><td>Neat liquid</td><td>5-FU</td><td>&#x02212;23</td><td>NS</td><td>&#x02212;16</td><td>NS</td><td>Increased</td><td>Lipid disruption</td><td>(<xref ref-type="bibr" rid="CR11">11</xref>)</td></tr><tr><td>PG/W (20:80)</td><td>5-FU</td><td>&#x02212;22</td><td>&#x000a0;</td><td>&#x02212;13</td><td>&#x000a0;</td><td>&#x000a0;</td><td>Freezing point depression</td><td>(<xref ref-type="bibr" rid="CR12">12</xref>)</td></tr><tr><td>PG/W (50:50)</td><td>5-FU</td><td>&#x02212;23</td><td>&#x000a0;</td><td>&#x02212;15</td><td>&#x000a0;</td><td>&#x000a0;</td><td>Freezing point depression</td><td>(<xref ref-type="bibr" rid="CR12">12</xref>)</td></tr><tr><td>PG/W (80:20)</td><td>5-FU</td><td>&#x02212;24</td><td>&#x000a0;</td><td>&#x02212;15</td><td>&#x000a0;</td><td>&#x000a0;</td><td>Freezing point depression</td><td>(<xref ref-type="bibr" rid="CR12">12</xref>)</td></tr><tr><td rowspan="4">1,8-cineole</td><td>Neat liquid</td><td>5-FU</td><td>&#x02212;23</td><td>50</td><td>&#x02212;16</td><td>50</td><td>Increased</td><td>Lipid disruption</td><td>(<xref ref-type="bibr" rid="CR11">11</xref>)</td></tr><tr><td>PG/W (20:80)</td><td>5-FU</td><td>&#x02212;24</td><td>18</td><td>&#x02212;18</td><td>NS</td><td>NS</td><td>Lipid disruption</td><td>(<xref ref-type="bibr" rid="CR12">12</xref>)</td></tr><tr><td>PG/W (50:50)</td><td>5-FU</td><td>&#x02212;24</td><td>37</td><td>&#x02212;17</td><td>NS</td><td>NS</td><td>Lipid disruption</td><td>(<xref ref-type="bibr" rid="CR12">12</xref>)</td></tr><tr><td>PG/W (80:20)</td><td>5-FU</td><td>&#x02212;28</td><td>60</td><td>&#x02212;17</td><td>22</td><td>NS</td><td>Lipid disruption</td><td>(<xref ref-type="bibr" rid="CR12">12</xref>)</td></tr><tr><td rowspan="4">Nerolidol</td><td>Neat liquid</td><td>5-FU</td><td>&#x02212;4.2</td><td>Increased</td><td>&#x02212;4</td><td>Increased</td><td>Absent</td><td>Lipid disruption</td><td>(<xref ref-type="bibr" rid="CR11">11</xref>)</td></tr><tr><td>PG/W (20:80)</td><td>5-FU</td><td>&#x02212;3</td><td>6</td><td>&#x02212;4</td><td>NS</td><td>NS</td><td>Lipid disruption</td><td>(<xref ref-type="bibr" rid="CR11">11</xref>)</td></tr><tr><td>PG/W (50:50)</td><td>5-FU</td><td>&#x02212;4</td><td>15</td><td>&#x02212;4</td><td>NS</td><td>NS</td><td>Lipid disruption</td><td>(<xref ref-type="bibr" rid="CR12">12</xref>)</td></tr><tr><td>PG/W (80:20)</td><td>5-FU</td><td>&#x02212;6</td><td>30</td><td>&#x02212;8</td><td>NS</td><td>NS</td><td>Lipid disruption</td><td>(<xref ref-type="bibr" rid="CR12">12</xref>)</td></tr><tr><td rowspan="4">Menthone</td><td>Neat liquid</td><td>5-FU</td><td>&#x02212;19.4</td><td>Increased</td><td>&#x02212;10</td><td>Increased</td><td>Absent</td><td>Lipid disruption</td><td>(<xref ref-type="bibr" rid="CR11">11</xref>)</td></tr><tr><td>PG/W (20:80)</td><td>5-FU</td><td>&#x02212;15</td><td>8</td><td>&#x02212;14</td><td>NS</td><td>NS</td><td>Lipid disruption</td><td>(<xref ref-type="bibr" rid="CR11">11</xref>)</td></tr><tr><td>PG/W (50:50)</td><td>5-FU</td><td>&#x02212;15</td><td>17</td><td>&#x02212;15</td><td>NS</td><td>NS</td><td>Lipid disruption</td><td>(<xref ref-type="bibr" rid="CR12">12</xref>)</td></tr><tr><td>PG/W (80:20)</td><td>5-FU</td><td>&#x02212;16</td><td>42</td><td>&#x02212;15</td><td>NS</td><td>NS</td><td>Lipid disruption</td><td>(<xref ref-type="bibr" rid="CR12">12</xref>)</td></tr><tr><td>Menthol</td><td>EtOHl (70% <italic>v</italic>/<italic>v</italic>)</td><td>Nicardipine HCl</td><td>NS</td><td>Decreased</td><td>Absent</td><td>Absent</td><td>Absent</td><td>Lipid extraction</td><td>(<xref ref-type="bibr" rid="CR21">21</xref>)</td></tr><tr><td>Carvone</td><td>EtOH (70% <italic>v</italic>/<italic>v</italic>)</td><td>Nicardipine HCl</td><td>NS</td><td>Decreased</td><td>Absent</td><td>Absent</td><td>Absent</td><td>Lipid extraction</td><td>(<xref ref-type="bibr" rid="CR21">21</xref>)</td></tr><tr><td rowspan="2">Carvacrol</td><td>EtOH (50% <italic>v</italic>/<italic>v</italic>)</td><td>Haloperidol</td><td>&#x02212;16</td><td>Increased</td><td>&#x02212;12</td><td>Decreased</td><td>+20</td><td>Lipid disruption and extraction</td><td>(<xref ref-type="bibr" rid="CR26">26</xref>)</td></tr><tr><td>PG</td><td>&#x000a0;</td><td>&#x02212;5</td><td>NS</td><td>&#x02212;7</td><td>Decreased</td><td>Absent</td><td>Lipid disruption and extraction</td><td>(<xref ref-type="bibr" rid="CR27">27</xref>)</td></tr><tr><td rowspan="2">Linalool</td><td>EtOH (50% <italic>v</italic>/<italic>v</italic>)</td><td>Haloperidol</td><td>&#x02212;32</td><td>Decreased</td><td>&#x02212;15</td><td>Decreased</td><td>&#x02212;5</td><td>Lipid disruption and extraction</td><td>(<xref ref-type="bibr" rid="CR26">26</xref>)</td></tr><tr><td>PG</td><td>&#x000a0;</td><td>&#x02212;5</td><td>NS</td><td>&#x02212;3.5</td><td>Decreased</td><td>Absent</td><td>Lipid disruption and extraction</td><td>(<xref ref-type="bibr" rid="CR27">27</xref>)</td></tr><tr><td rowspan="2">&#x003b1;-terpeniol</td><td>EtOH (50% <italic>v</italic>/<italic>v</italic>)</td><td>Haloperidol</td><td>&#x02212;32</td><td>Decreased</td><td>&#x02212;23</td><td>NS</td><td>&#x02212;12</td><td>Lipid disruption and extraction</td><td>(<xref ref-type="bibr" rid="CR26">26</xref>)</td></tr><tr><td>PG</td><td>&#x000a0;</td><td>&#x02212;5</td><td>NS</td><td>&#x02212;3.5</td><td>Decreased</td><td>+10</td><td>Lipid disruption and extraction</td><td>(<xref ref-type="bibr" rid="CR27">27</xref>)</td></tr><tr><td rowspan="2">Limonene oxide</td><td>EtOH (50% <italic>v</italic>/<italic>v</italic>)</td><td>Haloperidol</td><td>&#x000a0;</td><td>Coalescence</td><td>&#x000a0;</td><td>Coalescence</td><td>Absent</td><td>Lipid disruption and extraction</td><td>(<xref ref-type="bibr" rid="CR17">17</xref>)</td></tr><tr><td>PG</td><td>&#x000a0;</td><td>&#x02212;2</td><td>NS</td><td>&#x02212;3</td><td>&#x000a0;</td><td>Absent</td><td>Lipid disruption</td><td>(<xref ref-type="bibr" rid="CR17">17</xref>)</td></tr><tr><td rowspan="2">Pinene oxide</td><td>EtOH (50% v/v)</td><td>Haloperidol</td><td>&#x02212;26</td><td>Decreased</td><td>&#x02212;24</td><td>NS</td><td>Absent</td><td>Lipid disruption and extraction</td><td>(<xref ref-type="bibr" rid="CR17">17</xref>)</td></tr><tr><td>PG</td><td>&#x000a0;</td><td>&#x02212;5.5</td><td>Decreased</td><td>&#x02212;6</td><td>Decreased</td><td>Absent</td><td>Lipid fluidization</td><td>(<xref ref-type="bibr" rid="CR17">17</xref>)</td></tr></tbody></table><table-wrap-foot><p><italic>NS</italic> Not significant, <italic>5-FU</italic> 5-fluorouracil, <italic>PG</italic> propylene glycol, <italic>EtOH</italic> Ethanol, <italic>w</italic> water</p></table-wrap-foot></table-wrap><table-wrap id="Tab3"><label>Table&#x000a0;III</label><caption><p>Influence of Terpene Treatment on Spectroscopic Attributes of Drugs</p></caption><table frame="hsides" rules="groups"><thead><tr><th rowspan="3">Terpene</th><th rowspan="3">Drug</th><th rowspan="3">Skin</th><th colspan="8">C&#x02013;H Stretching</th><th rowspan="3">Proposed Mechanism</th><th rowspan="3">Ref.</th></tr><tr><th colspan="4">Asymmetric</th><th colspan="4">Symmetric</th></tr><tr><th>Peak Height</th><th>Percent Decrease</th><th>Peak Area</th><th>Percent Decrease</th><th>Peak Height</th><th>Percent Decrease</th><th>Peak Area</th><th>Percent Decrease</th></tr></thead><tbody><tr><td>Control (50% v/v EtOH)</td><td>Haloperidol</td><td>Human</td><td>0.44&#x02009;&#x000b1;&#x02009;0.0</td><td>9.55&#x02009;&#x000b1;&#x02009;0.55</td><td>14.02&#x02009;&#x000b1;&#x02009;1.1</td><td>9.75&#x02009;&#x000b1;&#x02009;1.44</td><td>0.25&#x02009;&#x000b1;&#x02009;0.01</td><td>6.35&#x02009;&#x000b1;&#x02009;0.94</td><td>2.49&#x02009;&#x000b1;&#x02009;0.16</td><td>5.45&#x02009;&#x000b1;&#x02009;0.68</td><td>NS</td><td>(<xref ref-type="bibr" rid="CR17">17</xref>)</td></tr><tr><td>Limonene oxide</td><td>Haloperidol</td><td>Human</td><td>0.31&#x02009;&#x000b1;&#x02009;0.01</td><td>21.04&#x02009;&#x000b1;&#x02009;1.19</td><td>9.65&#x02009;&#x000b1;&#x02009;0.2</td><td>20.89&#x02009;&#x000b1;&#x02009;0.97</td><td>0.18&#x02009;&#x000b1;&#x02009;0.01</td><td>20.99&#x02009;&#x000b1;&#x02009;1.46</td><td>1.71&#x02009;&#x000b1;&#x02009;0.17</td><td>23.39&#x02009;&#x000b1;&#x02009;2.39</td><td>NS</td><td>&#x000a0;</td></tr><tr><td>Pinene oxide</td><td>Haloperidol</td><td>Human</td><td>0.34&#x02009;&#x000b1;&#x02009;0.01</td><td>13.08&#x02009;&#x000b1;&#x02009;1.02</td><td>10.25&#x02009;&#x000b1;&#x02009;0.4</td><td>15.38&#x02009;&#x000b1;&#x02009;0.36</td><td>0.2&#x02009;&#x000b1;&#x02009;0.01</td><td>11.94&#x02009;&#x000b1;&#x02009;0.15</td><td>1.78 v 0.06</td><td>14.84&#x02009;&#x000b1;&#x02009;0.51</td><td>NS</td><td>&#x000a0;</td></tr><tr><td>Control (PG)</td><td>Haloperidol</td><td>Human</td><td>0.43&#x02009;&#x000b1;&#x02009;0.05</td><td>12.91&#x02009;&#x000b1;&#x02009;2.6</td><td>14.04&#x02009;&#x000b1;&#x02009;1.41</td><td>13.59&#x02009;&#x000b1;&#x02009;2.08</td><td>0.27&#x02009;&#x000b1;&#x02009;0.06</td><td>12.85&#x02009;&#x000b1;&#x02009;1.89</td><td>2.71&#x02009;&#x000b1;&#x02009;0.56</td><td>11.68&#x02009;&#x000b1;&#x02009;2.59</td><td>NS</td><td>(<xref ref-type="bibr" rid="CR17">17</xref>)</td></tr><tr><td>Limonene oxide</td><td>Haloperidol</td><td>Human</td><td>0.36&#x02009;&#x000b1;&#x02009;0.02</td><td>12.22&#x02009;&#x000b1;&#x02009;1.95</td><td>11.54&#x02009;&#x000b1;&#x02009;0.65</td><td>12.68&#x02009;&#x000b1;&#x02009;1.18</td><td>0.21&#x02009;&#x000b1;&#x02009;0.01</td><td>11.87&#x02009;&#x000b1;&#x02009;1.17</td><td>2.07&#x02009;&#x000b1;&#x02009;0.1</td><td>11.07&#x02009;&#x000b1;&#x02009;1.21</td><td>NS</td><td>&#x000a0;</td></tr><tr><td>Pinene oxide</td><td>Haloperidol</td><td>Human</td><td>0.38&#x02009;&#x000b1;&#x02009;0.01</td><td>9.58&#x02009;&#x000b1;&#x02009;1.41</td><td>12.13&#x02009;&#x000b1;&#x02009;0.59</td><td>8.88&#x02009;&#x000b1;&#x02009;0.89</td><td>0.23&#x02009;&#x000b1;&#x02009;0.01</td><td>9.57&#x02009;&#x000b1;&#x02009;1.36</td><td>2.14&#x02009;&#x000b1;&#x02009;0.04</td><td>10.81&#x02009;&#x000b1;&#x02009;1.96</td><td>NS</td><td>&#x000a0;</td></tr><tr><td>Control</td><td>Haloperidol</td><td>Human</td><td>0.43&#x02009;&#x000b1;&#x02009;0.05</td><td>12.91&#x02009;&#x000b1;&#x02009;2.6</td><td>14.04&#x02009;&#x000b1;&#x02009;1.41</td><td>13.59&#x02009;&#x000b1;&#x02009;2.08</td><td>0.27&#x02009;&#x000b1;&#x02009;0.06</td><td>12.85&#x02009;&#x000b1;&#x02009;1.89</td><td>2.71&#x02009;&#x000b1;&#x02009;0.56</td><td>11.68&#x02009;&#x000b1;&#x02009;2.59</td><td>&#x000a0;</td><td>(<xref ref-type="bibr" rid="CR27">27</xref>)</td></tr><tr><td>Carvacrol</td><td>Haloperidol</td><td>Human</td><td>0.35&#x02009;&#x000b1;&#x02009;0.08</td><td>28.417&#x02009;&#x000b1;&#x02009;1.83</td><td>11.31&#x02009;&#x000b1;&#x02009;1.48</td><td>29.81&#x02009;&#x000b1;&#x02009;1.71</td><td>0.2&#x02009;&#x000b1;&#x02009;0.04</td><td>2.71&#x02009;&#x000b1;&#x02009;0.56</td><td>2.06&#x02009;&#x000b1;&#x02009;0.35</td><td>29.43&#x02009;&#x000b1;&#x02009;1.85</td><td>Lipid disruption and extraction</td><td>&#x000a0;</td></tr><tr><td>Linalool</td><td>Haloperidol</td><td>Human</td><td>0.33&#x02009;&#x000b1;&#x02009;0.06</td><td>25.73&#x02009;&#x000b1;&#x02009;2.25</td><td>11.44&#x02009;&#x000b1;&#x02009;1.81</td><td>26.33&#x02009;&#x000b1;&#x02009;4.18</td><td>0.18&#x02009;&#x000b1;&#x02009;0.04</td><td>2.01&#x02009;&#x000b1;&#x02009;0.38</td><td>2.01&#x02009;&#x000b1;&#x02009;0.38</td><td>27.94&#x02009;&#x000b1;&#x02009;5.44</td><td>Lipid disruption and extraction</td><td>&#x000a0;</td></tr><tr><td>Terpineol</td><td>Haloperidol</td><td>Human</td><td>0.27&#x02009;&#x000b1;&#x02009;0.05</td><td>26.11&#x02009;&#x000b1;&#x02009;0.27</td><td>10.65&#x02009;&#x000b1;&#x02009;1.36</td><td>29.07&#x02009;&#x000b1;&#x02009;1.85</td><td>0.15&#x02009;&#x000b1;&#x02009;0.02</td><td>1.62&#x02009;&#x000b1;&#x02009;0.18</td><td>1.62&#x02009;&#x000b1;&#x02009;0.18</td><td>28.24&#x02009;&#x000b1;&#x02009;2.78</td><td>Lipid disruption and extraction</td><td>&#x000a0;</td></tr><tr><td>Control</td><td>Nicardipine hydrochloride</td><td>Rat</td><td>0.25&#x02009;&#x000b1;&#x02009;0.01</td><td>21.8&#x02009;&#x000b1;&#x02009;0.01</td><td>NS</td><td>NS</td><td>0.19&#x02009;&#x000b1;&#x02009;0.0</td><td>24&#x02009;&#x000b1;&#x02009;0.01</td><td>NS</td><td>NS</td><td>&#x000a0;</td><td>(<xref ref-type="bibr" rid="CR21">21</xref>)</td></tr><tr><td>Menthol (1%)</td><td>Nicardipine hydrochloride</td><td>Rat</td><td>0.21&#x02009;&#x000b1;&#x02009;0.01</td><td>16&#x02009;&#x000b1;&#x02009;0.01</td><td>NS</td><td>NS</td><td>0.18&#x02009;&#x000b1;&#x02009;0.01</td><td>5.26&#x02009;&#x000b1;&#x02009;0.01</td><td>NS</td><td>NS</td><td>Lipid extraction</td><td>&#x000a0;</td></tr><tr><td>Menthol (2%)</td><td>Nicardipine hydrochloride</td><td>Rat</td><td>0.2&#x02009;&#x000b1;&#x02009;0.01</td><td>20&#x02009;&#x000b1;&#x02009;0.01</td><td>NS</td><td>NS</td><td>0.16&#x02009;&#x000b1;&#x02009;0.01</td><td>15.79&#x02009;&#x000b1;&#x02009;0.01</td><td>NS</td><td>NS</td><td>Lipid extraction</td><td>&#x000a0;</td></tr><tr><td>Menthol (5%)</td><td>Nicardipine hydrochloride</td><td>Rat</td><td>0.16&#x02009;&#x000b1;&#x02009;0.01</td><td>36&#x02009;&#x000b1;&#x02009;0.01</td><td>NS</td><td>NS</td><td>0.09&#x02009;&#x000b1;&#x02009;0.01</td><td>52.63&#x02009;&#x000b1;&#x02009;0.01</td><td>NS</td><td>NS</td><td>Lipid extraction</td><td>&#x000a0;</td></tr><tr><td>Menthol (8%)</td><td>Nicardipine hydrochloride</td><td>Rat</td><td>0.11&#x02009;&#x000b1;&#x02009;0.01</td><td>56&#x02009;&#x000b1;&#x02009;0.01</td><td>NS</td><td>NS</td><td>0.07&#x02009;&#x000b1;&#x02009;0.0</td><td>63.15&#x02009;&#x000b1;&#x02009;0.0</td><td>NS</td><td>NS</td><td>Lipid extraction</td><td>&#x000a0;</td></tr><tr><td>Menthol (10%)</td><td>Nicardipine hydrochloride</td><td>Rat</td><td>0.1&#x02009;&#x000b1;&#x02009;0.02</td><td>60&#x02009;&#x000b1;&#x02009;0.01</td><td>NS</td><td>NS</td><td>0.06&#x02009;&#x000b1;&#x02009;0.0</td><td>68.42&#x02009;&#x000b1;&#x02009;0.0</td><td>NS</td><td>NS</td><td>Lipid extraction</td><td>&#x000a0;</td></tr><tr><td>Menthol (12%)</td><td>Nicardipine hydrochloride</td><td>Rat</td><td>0.1&#x02009;&#x000b1;&#x02009;0.01</td><td>60&#x02009;&#x000b1;&#x02009;0.01</td><td>NS</td><td>NS</td><td>0.06&#x02009;&#x000b1;&#x02009;0.01</td><td>68.42&#x02009;&#x000b1;&#x02009;0.01</td><td>NS</td><td>NS</td><td>Lipid extraction</td><td>&#x000a0;</td></tr><tr><td>Water</td><td>Nicardipine hydrochloride</td><td>Rat</td><td>0.32&#x02009;&#x000b1;&#x02009;0.01</td><td>&#x02013;</td><td>NS</td><td>NS</td><td>0.25&#x02009;&#x000b1;&#x02009;0.01</td><td>&#x02013;</td><td>NS</td><td>NS</td><td>&#x000a0;</td><td>(<xref ref-type="bibr" rid="CR23">23</xref>)</td></tr><tr><td>70% EtOH</td><td>&#x000a0;</td><td>Rat</td><td>0.25&#x02009;&#x000b1;&#x02009;0.01</td><td>21.8&#x02009;&#x000b1;&#x02009;0.08</td><td>NS</td><td>NS</td><td>0.19&#x02009;&#x000b1;&#x02009;0.01</td><td>24.0&#x02009;&#x000b1;&#x02009;0.01</td><td>NS</td><td>NS</td><td>Lipid extraction</td><td>&#x000a0;</td></tr><tr><td>8% Carvone</td><td>Nicardipine hydrochloride</td><td>Rat</td><td>0.1&#x02009;&#x000b1;&#x02009;0.01</td><td>64&#x02009;&#x000b1;&#x02009;0.01</td><td>NS</td><td>NS</td><td>0.07&#x02009;&#x000b1;&#x02009;0.07</td><td>63.16&#x02009;&#x000b1;&#x02009;0.01</td><td>NS</td><td>NS</td><td>Lipid extraction</td><td>&#x000a0;</td></tr><tr><td>Control (60% <italic>v</italic>/<italic>v</italic> EtOH)</td><td>Nimodipine</td><td>Rat</td><td>0.26&#x02009;&#x000b1;&#x02009;0.01</td><td>23.52&#x02009;&#x000b1;&#x02009;0.01</td><td>NS</td><td>NS</td><td>0.19&#x02009;&#x000b1;&#x02009;0.01</td><td>24&#x02009;&#x000b1;&#x02009;0.01</td><td>NS</td><td>NS</td><td>&#x000a0;</td><td>(<xref ref-type="bibr" rid="CR24">24</xref>)</td></tr><tr><td>Carvone (2%)</td><td>Nimodipine</td><td>Rat</td><td>0.21&#x02009;&#x000b1;&#x02009;0.01</td><td>19.23&#x02009;&#x000b1;&#x02009;0.01</td><td>NS</td><td>NS</td><td>0.16&#x02009;&#x000b1;&#x02009;0.01</td><td>15.799&#x02009;&#x000b1;&#x02009;0.01</td><td>NS</td><td>NS</td><td>Lipid bilayer disruption and partial extraction of SC lipids</td><td>&#x000a0;</td></tr><tr><td>Carvone (8%)</td><td>Nimodipine</td><td>Rat</td><td>0.13&#x02009;&#x000b1;&#x02009;0.01</td><td>50&#x02009;&#x000b1;&#x02009;0.01</td><td>NS</td><td>NS</td><td>0.08&#x02009;&#x000b1;&#x02009;0.01</td><td>57.83&#x02009;&#x000b1;&#x02009;0.01</td><td>NS</td><td>NS</td><td>Lipid bilayer disruption and partial extraction of SC lipids</td><td>&#x000a0;</td></tr><tr><td>Carvone (10%)</td><td>Nimodipine</td><td>Rat</td><td>0.11&#x02009;&#x000b1;&#x02009;0.01</td><td>57.69&#x02009;&#x000b1;&#x02009;0.01</td><td>NS</td><td>NS</td><td>0.07&#x02009;&#x000b1;&#x02009;0.01</td><td>63.15&#x02009;&#x000b1;&#x02009;0.01</td><td>NS</td><td>NS</td><td>Lipid bilayer disruption and partial extraction of SC lipids</td><td>&#x000a0;</td></tr><tr><td>Control</td><td>Tamoxifen</td><td>Porcine</td><td>0.34&#x02009;&#x000b1;&#x02009;0.01</td><td>&#x02013;</td><td>0.72&#x02009;&#x000b1;&#x02009;0.1</td><td>&#x02013;</td><td>0.23&#x02009;&#x000b1;&#x02009;0.01</td><td>&#x02013;</td><td>2.4&#x02009;&#x000b1;&#x02009;0.1</td><td>&#x02013;</td><td>&#x02013;</td><td>(<xref ref-type="bibr" rid="CR30">30</xref>)</td></tr><tr><td>EtOH</td><td>Tamoxifen</td><td>Porcine</td><td>0.26&#x02009;&#x000b1;&#x02009;0.01</td><td>22.09</td><td>5.25&#x02009;&#x000b1;&#x02009;0.0</td><td>21.86</td><td>0.16&#x02009;&#x000b1;&#x02009;0.01</td><td>32.76</td><td>1.78&#x02009;&#x000b1;&#x02009;0.02</td><td>25.96</td><td>&#x02013;</td><td>&#x000a0;</td></tr><tr><td>Eugenol-EtOH</td><td>Tamoxifen</td><td>Porcine</td><td>0.17&#x02009;&#x000b1;&#x02009;0.01</td><td>49.25</td><td>3.80&#x02009;&#x000b1;&#x02009;0.0</td><td>42.54</td><td>0.12&#x02009;&#x000b1;&#x02009;0.0</td><td>48.28</td><td>1.77&#x02009;&#x000b1;&#x02009;0.01</td><td>26.33</td><td>Lipid extraction and improvement in partitioning of drug in SC</td><td>&#x000a0;</td></tr><tr><td><italic>d</italic>-limonene-EtOH</td><td>Tamoxifen</td><td>Porcine</td><td>0.15&#x02009;&#x000b1;&#x02009;0.01</td><td>54.03</td><td>3.01&#x02009;&#x000b1;&#x02009;0.1</td><td>55.16</td><td>0.09&#x02009;&#x000b1;&#x02009;0.0</td><td>62.5</td><td>0.86&#x02009;&#x000b1;&#x02009;0.06</td><td>64.23</td><td>Lipid extraction and improvement in partitioning of drug in SC</td><td>&#x000a0;</td></tr><tr><td>Menthone-EtOH</td><td>&#x000a0;</td><td>Porcine</td><td>0.15&#x02009;&#x000b1;&#x02009;0.01</td><td>56.12</td><td>3.13&#x02009;&#x000b1;&#x02009;0.43</td><td>53.39</td><td>0.08&#x02009;&#x000b1;&#x02009;0.0</td><td>64.66</td><td>0.86&#x02009;&#x000b1;&#x02009;0.06</td><td>66.72</td><td>Lipid extraction</td><td>&#x000a0;</td></tr><tr><td>EtOH</td><td>Insulin</td><td>Rat</td><td>NS</td><td>NS</td><td>0.88&#x02009;&#x000b1;&#x02009;0.05</td><td>81.39</td><td>NS</td><td>NS</td><td>NS</td><td>NS</td><td>&#x000a0;</td><td>(<xref ref-type="bibr" rid="CR31">31</xref>)</td></tr><tr><td>Cineole/EtOH</td><td>Insulin</td><td>Rat</td><td>NS</td><td>NS</td><td>2.8&#x02009;&#x000b1;&#x02009;1.11</td><td>62.31</td><td>NS</td><td>NS</td><td>NS</td><td>NS</td><td>Lipid extraction</td><td>&#x000a0;</td></tr><tr><td>Pulgeon/</td><td>Insulin</td><td>Rat</td><td>NS</td><td>NS</td><td>3.61&#x02009;&#x000b1;&#x02009;0.01</td><td>59.84</td><td>NS</td><td>NS</td><td>NS</td><td>NS</td><td>Lipid extraction</td><td>&#x000a0;</td></tr><tr><td>Menthol /</td><td>Insulin</td><td>Rat</td><td>NS</td><td>NS</td><td>3.57&#x02009;&#x000b1;&#x02009;1.26</td><td>49.5</td><td>NS</td><td>NS</td><td>NS</td><td>NS</td><td>Lipid extraction</td><td>&#x000a0;</td></tr><tr><td>Neat menthone</td><td>Insulin</td><td>Rat</td><td>NS</td><td>NS</td><td>2.58&#x02009;&#x000b1;&#x02009;0.86</td><td>47.13</td><td>NS</td><td>NS</td><td>NS</td><td>NS</td><td>Lipid extraction</td><td>&#x000a0;</td></tr></tbody></table><table-wrap-foot><p><italic>EtOH</italic> Ethanol, <italic>PG</italic> propylene glycol, <italic>NS</italic> not specified, <italic>5- FU</italic> 5-Fluorouracil</p></table-wrap-foot></table-wrap></p><p>These techniques can further be complemented with microscopic studies in order to assess the effect of terpenes on various domains of skin. Further, application of quantitative correlation between permeation effects and physicochemical descriptors of terpenes by QSAR models can provide insights into the possible mechanisms responsible for skin permeation enhancement activity.</p><p>In view of the renewed interest in herbal components, this article is aimed at reviewing the use of terpenes as drug penetration enhancers in transdermal drug delivery and to discuss the possible mechanisms for this activity.</p></sec><sec id="Sec2"><title>TERPENES AND TERPENOIDS</title><p>Terpenes and terpenoids are usually the constituents of volatile oil. Several natural sources and their major terpene content are summarized in Table <xref rid="Tab4" ref-type="table">IV</xref>. The basic chemical structure consists of a number of repeated isoprene (C<sub>5</sub>H<sub>8</sub>) units, which is used to classify terpenes. Thus, monoterpenes have two isoprene units (C<sub>10</sub>), sesquiterpenes have three (C<sub>15</sub>), and diterpenes have four (C<sub>20</sub>), etc. Terpenes may also be classified as acyclic/linear, monocyclic and bicyclic.
<table-wrap id="Tab4"><label>Table&#x000a0;IV</label><caption><p>Major Components of Terpenes From Natural Sources</p></caption><table frame="hsides" rules="groups"><thead><tr><th>Source</th><th>Botanical Name</th><th>Main Terpene Component</th><th>Ref.</th></tr></thead><tbody><tr><td>Angelica root</td><td><italic>Angelica archngelica</italic></td><td>&#x003b2;-Phellandrene, &#x003b1;-phellandrene, &#x003b1;-pinene</td><td>(<xref ref-type="bibr" rid="CR34">34</xref>)</td></tr><tr><td><italic>Anisi stellati fructus</italic></td><td><italic>Illicium verum</italic></td><td>Monoterpenoid hydrocarbon (limonene, &#x003b1;-pinene)</td><td>(<xref ref-type="bibr" rid="CR34">34</xref>)</td></tr><tr><td><italic>Apti fructus</italic></td><td><italic>Apium graveolens</italic></td><td>Limonene</td><td>(<xref ref-type="bibr" rid="CR34">34</xref>)</td></tr><tr><td><italic>Basilici herba</italic></td><td><italic>Osimum basilicum</italic></td><td>Linalool eugenol, scimene, cineole</td><td>(<xref ref-type="bibr" rid="CR34">34</xref>)</td></tr><tr><td>Cajuput</td><td><italic>Melaleuca leucadendron</italic></td><td>1,8-cineole, &#x003b1;-terpineol, <italic>d</italic>-limonene</td><td>(<xref ref-type="bibr" rid="CR35">35</xref>)</td></tr><tr><td>Cardamom</td><td><italic>Elettaria cardamomum</italic></td><td>1,8-Cineole, &#x003b1;-terpineol, &#x003b1;-terpinyl acetate</td><td>(<xref ref-type="bibr" rid="CR35">35</xref>)</td></tr><tr><td><italic>Carvi fructus</italic></td><td><italic>Carum carvi</italic></td><td>(<italic>S</italic>)-(+)-Carvone, &#x000ae;-(+)-limonene, &#x003b1;-pinene, cpinene, dihydrocarvone, dihydrocaveol</td><td>(<xref ref-type="bibr" rid="CR34">34</xref>)</td></tr><tr><td><italic>Caryophylli flos</italic></td><td><italic>Eugenia caryophyllus, Caryophyllus aromaticus</italic></td><td>Eugenol, eugenol acetate, &#x003b1;-pinene, &#x003b2;-caryophyllene and its oxide</td><td>(<xref ref-type="bibr" rid="CR34">34</xref>)</td></tr><tr><td><italic>Coriandri fructus</italic></td><td><italic>Coriandrum sativum</italic></td><td><sc>d</sc>-(+)-linalool, monoterpene hydrocarbons (&#x003b1;-pinene, <italic>d</italic>-limonene, &#x003b3;-terpinene, &#x003c1;-cymene</td><td>(<xref ref-type="bibr" rid="CR34">34</xref>)</td></tr><tr><td><italic>Eucaluptus folium</italic></td><td><italic>Eucalyptus globulus</italic></td><td>1,8-Cineole, eucalyptol, moderate amounts of monoterpenes (&#x003c1;-cymene, &#x003b1;-pinene</td><td>(<xref ref-type="bibr" rid="CR34">34</xref>)</td></tr><tr><td><italic>Foeniculi fructus</italic></td><td><italic>Foeniculum vulgare</italic></td><td><italic>Trans</italic>-anethol, some terpenoid hydrocarbons (&#x003b1;-pinene, &#x003b1;-phellandrene</td><td>(<xref ref-type="bibr" rid="CR34">34</xref>)</td></tr><tr><td><italic>Juniperi fructus</italic></td><td><italic>Juniperus communis</italic></td><td>&#x003b1;-Pinene, &#x003b2;-pinene, limonene, terpinen-4-ol, &#x003b1;-terpineol, borneol, geraniol</td><td>(<xref ref-type="bibr" rid="CR34">34</xref>)</td></tr><tr><td>Melissa</td><td><italic>Melissa officinalis</italic></td><td>Geranial, neral</td><td>(<xref ref-type="bibr" rid="CR35">35</xref>)</td></tr><tr><td><italic>Melissae folium</italic></td><td><italic>Melissa officinalis</italic></td><td>Monoterpenes (citronellal, citral A, citral B),sesquiterpene (&#x003b2;-caryophyllene, germacrene D)</td><td>(<xref ref-type="bibr" rid="CR34">34</xref>)</td></tr><tr><td>Myrtle</td><td><italic>Myrtus communis</italic></td><td>1,8-Cineole, &#x003b1;-pinene, myrtenyl acetate</td><td>(<xref ref-type="bibr" rid="CR35">35</xref>)</td></tr><tr><td>Niaouli</td><td><italic>Melaleuca virdiflora</italic></td><td>1,8-Cineole, &#x003b1;-pinene, &#x003b1;-terpineol, <italic>d</italic>-limonene</td><td>(<xref ref-type="bibr" rid="CR35">35</xref>)</td></tr><tr><td>Orange</td><td><italic>Citrus aurantium</italic></td><td><italic>d</italic>-Limonene</td><td>(<xref ref-type="bibr" rid="CR35">35</xref>)</td></tr></tbody></table></table-wrap></p><p>Numerous terpenes have been used as antispasmodics, carminatives, flavoring agents, perfumes etc. For example, menthol is traditionally used in inhalation pharmaceuticals and has a mild antipruritic effect when incorporated into emollient preparations. However, the potential of terpenes as percutaneous absorption enhancer was suggested (<xref ref-type="bibr" rid="CR5">5</xref>). Several cyclic terpenes like cineole, <italic>d</italic>-limonene, and &#x003b1;-pinene have been intensively investigated as penetration enhancers.</p><sec id="Sec3"><title><italic>d</italic>-Limonene</title><p>Okabe <italic>et al.</italic> reported the effect of ethanolic solution of <italic>d</italic>-limonene on percutaneous absorption of indomethacin and ketoprofen. Limonene was found to be essential for increasing the penetration of poorly permeable drugs. However, enhanced permeability of drugs cannot be easily maintained due to difficulty in sustaining high activity of enhancers during the applied period (<xref ref-type="bibr" rid="CR36">36</xref>,<xref ref-type="bibr" rid="CR37">37</xref>). In order to maintain the activity of the enhancer, Okabe <italic>et al.</italic> (<xref ref-type="bibr" rid="CR5">5</xref>) employed a rate limiting membrane to control the permeation of ethanol used along with <italic>d</italic>-limonene. The cooperative effect of ethanol and <italic>d</italic>-limonene was reported to be an effective binary enhancer system (<xref ref-type="bibr" rid="CR5">5</xref>,<xref ref-type="bibr" rid="CR37">37</xref>,<xref ref-type="bibr" rid="CR38">38</xref>). The enhancement of ethanol released on addition of <italic>d</italic>-limonene was found to be due to a change in structure of the adhesive layer of the transdermal patch because of its high affinity for <italic>d</italic>-limonene. The formulated system yielded high steady state permeation of drugs for a long period. The enhancement action was mainly attributed to the improved diffusivity of indomethacin in skin because the lag time for permeation was greatly shortened (<xref ref-type="bibr" rid="CR5">5</xref>).</p><p>Ohara <italic>et al.</italic> evaluated the combined effect of <italic>d</italic>-limonene and temperature on the skin permeation of ketoprofen across rat skin. The apparent penetration rate (<italic>R</italic><sub>p</sub>) increased sigmoidally with increase in the temperature, and at lower temperature <italic>R</italic><sub>p</sub> was almost constant. A linear relationship was observed when the skin was pretreated with 30% <italic>v</italic>/<italic>v</italic> ethanol without <italic>d</italic>-limonene. However, Arrhenius plots of permeability coefficient value obtained after skin pretreatment with 1.5% <italic>w</italic>/<italic>v d</italic>-limonene in 30% <italic>v</italic>/<italic>v</italic> ethanol exhibited a convex curvature, suggesting that skin structure was altered with increase in temperature (<xref ref-type="bibr" rid="CR39">39</xref>).</p><p>Krishnaiah <italic>et al.</italic> evaluated a limonene-based transdermal therapeutic system for its ability to provide the desired steady state plasma concentration of nicorandil in human volunteers. The flux of nicorandil from the limonene-based hydroxy propyl methyl cellulose drug reservoir across EVA 2825 (Ethylene vinyl acetate coated with 28% copolymers) membrane decreased to 216&#x02009;&#x000b1;&#x02009;10&#x000a0;&#x003bc;g/cm<sup>2</sup>/h as compared to control (371&#x02009;&#x000b1;&#x02009;4&#x000a0;&#x003bc;g/cm<sup>2</sup>/h) indicating that EVA 2825 effectively functioned as a rate controlling membrane. The limonene-based drug reservoir was sandwiched between an adhesive coated EVA 2825-release liner composite and a backing membrane, and was heat-sealed to form a circular patch (20&#x000a0;cm<sup>2</sup>). This patch yielded a steady state plasma concentration of 21.3&#x000a0;ng/ml through 24&#x000a0;h in healthy human volunteers (<xref ref-type="bibr" rid="CR40">40</xref>). Hydrocarbon limonene was found to be more effective as penetration enhancer as compared to oxygenated linalool and cineole because it produced 26.5-fold greater permeation than control. Incorporation of limonene into an organogel-containing transdermal patch was observed to successfully deliver haloperidol at a sustained rate (<xref ref-type="bibr" rid="CR14">14</xref>).</p><p>Limonene was reported to enhance the permeation of nicardipine HCl (hydrophilic) and hydrocortisone (polar steroid) significantly higher as compared to fenchone and thymol. These findings conflicted with the results observed by other researchers. It has been recognized that hydrophilic terpenes capable of hydrogen bonding (such as fenchone and thymol) actively promoted the permeation of hydrophilic drugs, whereas, hydrocarbon terpenes (e.g. limonene) provided higher permeation for lipophilic drugs (<xref ref-type="bibr" rid="CR41">41</xref>,<xref ref-type="bibr" rid="CR42">42</xref>). It was revealed that the lipophilicity of the permeant, as well as the enhancer molecule played an important role in determining the penetration promoting activity (<xref ref-type="bibr" rid="CR13">13</xref>,<xref ref-type="bibr" rid="CR41">41</xref>,<xref ref-type="bibr" rid="CR43">43</xref>&#x02013;<xref ref-type="bibr" rid="CR50">50</xref>).</p></sec><sec id="Sec4"><title>Cineole</title><p>The effects of propylene glycol (PG)/water co-solvent systems and terpene penetration enhancers [1,8-cineole, menthone, nerolidol and (+)-limonene] on the absorption rate of 5-FU (a hydrophilic permeant) were investigated using excised human skin. Co-application of each terpene in PG co-solvent system significantly enhanced the permeation of 5-FU. The penetration-enhancement activity of terpene depended on the propylene glycol content in the vehicle. Maximum permeation of 5-FU was obtained from formulations containing terpenes dispersed in 80% PG, which when normalized to the flux obtained using respective PG-water mixture yielded enhancement ratios ranging from 24 to 4-fold, respectively, for 1,8-cineole and (+)-limonene. The data obtained from DSC analysis was analyzed to calculate the entropy change in skin lipids after treatment with different terpenes. The treatment with 1,8-cineole, menthone and nerolidol was found to produce less change in the entropy (as compared to control) of skin lipids than the treatment with (+)-limonene. This indicated fluidization or reduction in lipid order at normal skin temperature. However, the observed higher entropy change of skin lipids after treatment with (+)-limonene than the control was suggested to be predominantly indicative of freezing point depression effect. Therefore, the mild effect of freezing point depression of skin lipids after treatment with (+)-limonene was able to enhance the permeation of 5-FU only by 4-fold as compared to 24-fold enhancement produced by 1,8-cineole (<xref ref-type="bibr" rid="CR12">12</xref>).</p><p>The addition of cineole (3% <italic>w</italic>/<italic>v</italic>) to ethanol (47% <italic>v</italic>/<italic>v</italic>) increased the penetration of thyrotropin releasing hormone (TRH) across human epidermis to 0.92&#x02009;&#x000b1;&#x02009;0.03&#x000a0;&#x003bc;g/cm<sup>2</sup>/h from 0.27&#x02009;&#x000b1;&#x02009;0.01&#x000a0;&#x003bc;g/cm<sup>2</sup>/h. Although, carveol (3% <italic>w</italic>/<italic>v</italic>) and menthone (3% <italic>w</italic>/<italic>v</italic>) in combination with ethanol (47% <italic>v</italic>/<italic>v</italic>) increased the permeation of TRH to 1.07&#x02009;&#x000b1;&#x02009;0.02&#x000a0;&#x003bc;g/cm<sup>2</sup>/h and 1.05&#x02009;&#x000b1;&#x02009;0.03&#x000a0;&#x003bc;g/cm<sup>2</sup>/h, respectively, cineole showed most rapid attainment of steady state flux. It was interesting to note that neither ethanol alone nor the combination of any of the terpene and ethanol had any significant effect on the flux of TRH during a 2&#x02013;4&#x000a0;h period. This suggested that the initial binding and saturation of the epidermal membrane by TRH was not affected by these materials (<xref ref-type="bibr" rid="CR18">18</xref>).</p><p>Various oxygen-containing monoterpenes enhanced the transdermal flux of zidovudine in the following order: cineole &#x0003e; menthol &#x0003e; menthone ~ pulgeone ~ &#x003b1;-terpeniol &#x0003e; carvone. SC or vehicle partition-coefficient of zidovudine was not altered significantly (<italic>p</italic>&#x02009;&#x0003e;&#x02009;0.05) but the lag time required for zidovudine permeation was significantly reduced by all these terpenes. No significant difference in flux between vehicles, 1% or 2.5% <italic>w</italic>/<italic>v</italic> cineole was observed. As concentration of cineole was further increased to 5% and 10% <italic>w</italic>/<italic>v</italic> in vehicle, the flux was significantly enhanced by 56-fold and 65-fold, respectively. The observed difference in permeation enhancement activity was attributed to different thermodynamic activity of terpenes in the vehicle (<xref ref-type="bibr" rid="CR19">19</xref>). In another investigation, 1,8-cineole was found to increase the flux of zidovudine 18-fold but lag time also increased from 4.9 to 8.5&#x000a0;h (<xref ref-type="bibr" rid="CR20">20</xref>). Recent studies conducted by Heard revealed that enhancement of mefenamic acid using 1,8-cineole was due to &#x0201c;drag&#x0201d; or &#x0201c;pull&#x0201d; effect (<xref ref-type="bibr" rid="CR51">51</xref>). However, another study suggested intercalation of cineole into lipids and proteins by forming hydrogen bonds thus, altering the organization of SC (<xref ref-type="bibr" rid="CR52">52</xref>).</p></sec><sec id="Sec5"><title>Carvone</title><p>The permeation of nicardipine HCl was observed to increase markedly by incorporating carvone in hydroxypropylcellulose gel and a maximum flux of 244&#x02009;&#x000b1;&#x02009;2&#x000a0;&#x003bc;g/cm<sup>2</sup>/h was observed with an enhancement ratio of 7.9 when 12% <italic>w</italic>/<italic>w</italic> carvone was used as enhancer. The enhancement was attributed to partial lipid extraction of the SC (<xref ref-type="bibr" rid="CR23">23</xref>). The transdermal permeation of nimodipine across rat abdominal skin was found to increase from 1.67&#x02009;&#x000b1;&#x02009;0.03&#x000a0;mg/cm<sup>2</sup>/24&#x000a0;h to 3.68&#x02009;&#x000b1;&#x02009;0.06&#x000a0;mg/cm<sup>2</sup>/24&#x000a0;h when carvone (2% to 12% <italic>w</italic>/<italic>w</italic>) was used with HPMC gel. However, no significant difference in the permeability coefficient of nimodipine was observed by incorporating 12% <italic>w</italic>/<italic>w</italic> carvone (10.9&#x02009;&#x000b1;&#x02009;0.08) as compared to that obtained with 10% <italic>w</italic>/<italic>w</italic> of carvone (10.73&#x02009;&#x000b1;&#x02009;0.5&#x000a0;cm/h&#x02009;&#x000d7;&#x02009;10<sup>3</sup>; <xref ref-type="bibr" rid="CR24">24</xref>).</p></sec><sec id="Sec6"><title>Menthol</title><p>Menthol, a monocyclic monoterpene free from significant toxic effects, has been approved as a penetration enhancer in the transdermal delivery of several drugs (<xref ref-type="bibr" rid="CR53">53</xref>&#x02013;<xref ref-type="bibr" rid="CR55">55</xref>). Kabayashi <italic>et al.</italic> evaluated the combined effects of 1-menthol and ethanol as skin permeation enhancer, and derived two equations describing the permeability coefficient through full-thickness skin (<italic>P</italic><sub>FT</sub>) and the full-thickness skin/vehicle concentration ratio (<italic>C</italic><sub>FT</sub>/<italic>C</italic><sub>V</sub>) of drugs as a function of their octanol/vehicle partition coefficient (<italic>K</italic><sub>OV</sub>). A two-layer model was applied for skin. A nonlinear least-squares method was employed to determine six coefficients (three diffusion coefficients, the porosity of the SC, and two terms of the linear free energy relationship) using the two equations and experimentally obtained <italic>P</italic><sub>FT</sub> and <italic>C</italic><sub>FT</sub>/<italic>C</italic><sub>V</sub> values. Addition of <italic>l</italic>-menthol to water or ethanol (40%) improved the diffusion coefficient of morphine hydrochloride, atenolol, nifedipine and vinpocetine in lipid and pore pathways of the SC, whereas addition of ethanol to water and <italic>l</italic>-menthol (5%) improved the solubility of drugs in the vehicle and increased the contribution of the pore pathway towards whole skin permeation (<xref ref-type="bibr" rid="CR56">56</xref>).</p><p>The mechanism of <italic>l</italic>-menthol as an enhancer was examined using diclofenac as a hydrophobic drug and diclofenac sodium as a hydrophilic drug through ethanol-treated and untreated silicone membranes. Results indicated that <italic>l</italic>-menthol enhanced the permeation of both salts of drug through both lipid as well as pore pathways (<xref ref-type="bibr" rid="CR57">57</xref>).</p><p>Menthol has been shown to increase the skin absorption of testosterone by forming a eutectic mixture, thereby lowering its melting point drastically from 153.7&#x000b0;C to 39.9&#x000b0;C, as reflected by DSC studies. Hence, the skin permeation enhancement of testosterone by menthol was suggested to be due to increase in the solubility of testosterone accompanied with altered barrier properties of SC (<xref ref-type="bibr" rid="CR53">53</xref>).</p><p>Hydrogel-based patches of propranolol hydrochloride were formulated with and without (1%, 5%, 10% <italic>w</italic>/<italic>v</italic>) menthol as an enhancer. Permeation of propranolol hydrochloride across hairless mouse skin was significantly higher (<italic>p</italic>&#x02009;&#x0003c;&#x02009;0.05) from patches containing menthol. This observation might be due to the preferential distribution of menthol into the intercellular spaces of SC, which resulted in reversible disruption of SC lipid domains (<xref ref-type="bibr" rid="CR54">54</xref>).</p><p>In combination with 15% <italic>v</italic>/<italic>v</italic> ethanol, <italic>l</italic>-menthol (1% <italic>w</italic>/<italic>v</italic>) increased the permeability coefficient of methyl paraben about 16-fold, while it decreased the permeability coefficient of butyl paraben to 20% of the control value through guinea pig dorsal skin. A spin label study with SC showed that these enhancers increased the lipid bilayer fluidity and led to enhanced permeation of hydrophilic substances (<xref ref-type="bibr" rid="CR55">55</xref>).</p><p>Krishnaiah <italic>et al.</italic> observed marked enhancement in permeation of nicardipine hydrochloride from gel systems containing menthol (1&#x02013;12% <italic>w</italic>/<italic>w</italic>) through excised rat epidermis. The cumulative amounts of nicardipine hydrochloride that permeated over 24&#x000a0;h increased from 1.74&#x02009;&#x000b1;&#x02009;0.13 to 5.03&#x02009;&#x000b1;&#x02009;0.03&#x000a0;mg/cm<sup>2</sup>/24&#x000a0;h from the hydroxypropyl cellulose gels containing menthol. However, a lag period of 2&#x02013;3&#x000a0;h in the permeation of the drug was observed. The flux remained constant when menthol was employed at 2% <italic>w</italic>/<italic>w</italic> concentration. However, when concentrations greater than 5% <italic>w</italic>/<italic>w</italic> were used, there was a rapid increase in flux (<xref ref-type="bibr" rid="CR21">21</xref>). In addition, the study revealed that enhancement remained unaltered from the gel containing more than 8% <italic>w</italic>/<italic>w</italic> of menthol. There was a statistically insignificant (<italic>p</italic>&#x02009;&#x0003e;&#x02009;0.05) decrease in enhancement of drug permeation with 10 or 12% w/w of menthol. Menthol is reported to increase both the moisture uptake capacity as well as release rate of propranolol hydrochloride from polymeric films (<xref ref-type="bibr" rid="CR21">21</xref>). Further <italic>l</italic>-menthol (5% <italic>w</italic>/<italic>v</italic>) was found to significantly (<italic>p</italic>&#x02009;&#x0003c;&#x02009;0.05) enhance the pseudo steady state flux of zidovudine across human cadaver skin with an enhancement factor of 53. However, the lag time was observed to increase. Partitioning of <italic>l</italic>-menthol into skin was found to be poor thereby indicating that it might have lipid fluidizing activity on SC lipids (<xref ref-type="bibr" rid="CR20">20</xref>). Chang <italic>et al.</italic> evaluated a series of terpenes as enhancers for meloxicam gel. Maximum flux was obtained when menthol was used as permeation enhancer and its enhancing activity was attributed to its hydrogen bonding ability (<xref ref-type="bibr" rid="CR58">58</xref>). However, the study conducted by Anjos and coworkers revealed that <italic>l</italic>-menthol stabilized mainly in the central region of stratum corneum membranes, which interacted with the membrane lipids and resulted in disruption of hydrogen bonds in the polar membrane interface (<xref ref-type="bibr" rid="CR59">59</xref>). The combination of menthol and iontophoresis was suggested to enhance the <italic>in vitro</italic> permeation of methotrexate due to alteration of lipid-protein domains of mice skin (<xref ref-type="bibr" rid="CR60">60</xref>).</p><p>Few studies aimed at synthesizing <italic>o</italic>-alkyl and <italic>o</italic>-acylmenthol derivatives for increasing the permeation of drugs through skin. Among the synthesized compounds <italic>o</italic>-ethylmenthol (MET) showed greatest drug penetration activity and caused relatively little skin irritation (<xref ref-type="bibr" rid="CR61">61</xref>). The flux of ketoprofen was markedly increased by using small amount of MET. It was concluded that MET increased retention of drugs in the skin surface (<xref ref-type="bibr" rid="CR62">62</xref>). Obata <italic>et al.</italic> (<xref ref-type="bibr" rid="CR63">63</xref>) evaluated MET for their structural activity relationships employing an artificial neural network. Confocal scanning laser microscopy revealed that MET contributed to enhancement by lipid perturbation, thus enhancing drug diffusivity in skin lipids (<xref ref-type="bibr" rid="CR64">64</xref>).</p></sec><sec id="Sec7"><title>Nerolidol</title><p>The effects of fenchone, thymol, <italic>d</italic>-limonene and nerolidol on the percutaneous permeation of gel formulations of nicardipine hydrochloride, hydrocortisone, carbamazepine and tamoxifen were studied across hairless mouse skin. Nerolidol was found to be most effective in promoting permeation of all drugs (<xref ref-type="bibr" rid="CR13">13</xref>). The results were in accordance with other studies conducted for 5-FU (<xref ref-type="bibr" rid="CR65">65</xref>) and diclofenac sodium (<xref ref-type="bibr" rid="CR66">66</xref>). According to Cornwell and Barry, the effective permeation promoting activity of nerolidol was due to its amphiphilic structure that was suitable for alignment within the lipid lamellae and also for disruption of the highly organized packing of SC (<xref ref-type="bibr" rid="CR67">67</xref>). Nerolidol, at 2% <italic>w</italic>/<italic>v</italic> concentration was found to produce a 2-fold and 20-fold increase in the permeation of enoxaparin sodium (<xref ref-type="bibr" rid="CR68">68</xref>) and 5-FU (<xref ref-type="bibr" rid="CR65">65</xref>), respectively. An unsaturated sesquiterpene, &#x003b1;-bisabolol was reported to enhance permeation of 5-FU and triamcinolone acetonide by 17- and 73-fold across excised human skin due to lipid fluidization of SC (<xref ref-type="bibr" rid="CR69">69</xref>).</p></sec></sec><sec id="Sec8"><title>QUANTITATIVE STRUCTURAL ACTIVITY RELATIONSHIP (QSAR)</title><p>QSAR has been explored for relating the skin permeation of compounds to their physicochemical properties (<xref ref-type="bibr" rid="CR70">70</xref>). In 1990, Flynn compiled skin permeability coefficients across human skin from different literature sources and identified Log P as the most important factor for determining the permeability coefficients (<xref ref-type="bibr" rid="CR71">71</xref>). The subsequent QSAR studies raised interest in using QSAR for modeling skin permeation (<xref ref-type="bibr" rid="CR70">70</xref>,<xref ref-type="bibr" rid="CR72">72</xref>&#x02013;<xref ref-type="bibr" rid="CR82">82</xref>). These QSAR models provide an insight into the mechanism of skin penetration and guidance for predicting permeability of new compounds.</p><p>Ghafourian <italic>et al.</italic> constructed QSAR models for 34 terpenes, 16 pyrrolidinone derivatives and seven <italic>N</italic>-acetylprolinate esters with respect to several drugs (<xref ref-type="bibr" rid="CR83">83</xref>). These QSAR models were based on data of different sources and skin types, including human, rats and hairless mouse skins. However, the data needs more careful analysis when combined into a single dataset as it is difficult to explain the large variations, primarily due to inter-laboratory differences such as skin sample types and sources, solvent systems for enhancers and experimental protocols.</p><p>The Log <italic>p</italic> value of terpene (Table <xref rid="Tab5" ref-type="table">V</xref>) appears as a predictor in many QSAR models (<xref ref-type="bibr" rid="CR70">70</xref>,<xref ref-type="bibr" rid="CR84">84</xref>). Kang <italic>et al.</italic> determined permeability coefficient of different terpenes experimentally using human skin and employed non-linear regression model. Their results suggested that (1) liquid terpenes tend to produce better enhancing effects than solid terpenes; (2) triterpenes and tetraterpenes generally had poor penetration effect than other terpenes; (3) terpenes with larger Log <italic>p</italic> values were more effective enhancers than those with smaller Log P as it was easier for lipophilic terpenes to get mixed with SC intercellular lipids (for extraction or for lipid phase transition; <xref ref-type="bibr" rid="CR19">19</xref>,<xref ref-type="bibr" rid="CR83">83</xref>,<xref ref-type="bibr" rid="CR85">85</xref>,<xref ref-type="bibr" rid="CR86">86</xref>); (4) the liquid terpenes could form more number of hydrogen bonds with intercellular lipids of SC (<xref ref-type="bibr" rid="CR20">20</xref>,<xref ref-type="bibr" rid="CR25">25</xref>,<xref ref-type="bibr" rid="CR85">85</xref>); (5) terpenes with aldehyde and ester functional groups were found to be better enhancers (<xref ref-type="bibr" rid="CR85">85</xref>). In addition, the size of a terpene also determined the penetration ability. Smaller terpenes tended to be more active than the larger terpenes (<xref ref-type="bibr" rid="CR86">86</xref>). Furthermore, smaller alcoholic terpenes with a higher degree of unsaturation appeared to be good candidates for enhancing the permeation of hydrophilic drugs (<xref ref-type="bibr" rid="CR83">83</xref>). Cal and his coworkers investigated the absorption and elimination of different terpenes from human skin layers and observed terpinen-4-ol to accumulate in the skin to a greater extent when compared to pinenes (&#x003b1; and &#x003b2; pinene) and eucalyptol. This property was ascribed to the presence of polar groups, which increased its affinity towards polar region of SC and hydrophilic dermis. Almost negligible penetration was observed for pinenes in spite of the same log <italic>p</italic> values (<xref ref-type="bibr" rid="CR87">87</xref>). Fang <italic>et al.</italic> concluded that oxygen containing terpenes were more effective than hydrocarbon terpenes. In addition, oxygen containing terpenes with a bicyclic structure displayed a lesser permeation enhancing effect (<xref ref-type="bibr" rid="CR88">88</xref>).
<table-wrap id="Tab5"><label>Table&#x000a0;V</label><caption><p>Log <italic>p</italic> Values of Few Terpenes (<xref ref-type="bibr" rid="CR85">85</xref>)</p></caption><table frame="hsides" rules="groups"><thead><tr><th>Terpene</th><th>Log <italic>p</italic> Value</th><th>Terpene</th><th>Log <italic>p</italic> Value</th></tr></thead><tbody><tr><td>Carveol</td><td>2.68</td><td>(<italic>S</italic>)-(&#x02212;)-citronellal</td><td>3.48</td></tr><tr><td>(&#x02212;) dihydro carveol</td><td>2.92</td><td>Carvacrol</td><td>3.28</td></tr><tr><td>(+)-dihydro carveol</td><td>2.92</td><td>Citral</td><td>3.17</td></tr><tr><td>(+)-dihydrocarvone</td><td>2.47</td><td>Menthone</td><td>2.63</td></tr><tr><td>(&#x000b1;)-linalool</td><td>3.28</td><td>Nerol</td><td>3.28</td></tr><tr><td>(<italic>R</italic>)-(&#x02212;)-carvone</td><td>2.27</td><td>Thymol</td><td>3.28</td></tr><tr><td>(<italic>R</italic>)-(+)-pulgeone</td><td>2.56</td><td>&#x003b2;-cittronellal</td><td>3.38</td></tr><tr><td>Phytol retinol</td><td>8.66</td><td>&#x003b2;-carotene</td><td>15.51</td></tr><tr><td>Squalene</td><td>13.09</td><td>(&#x000b1;)-nerolidol</td><td>5.31</td></tr></tbody></table></table-wrap></p></sec><sec id="Sec9"><title><italic>IN VITRO</italic>/<italic>IN VIVO</italic> CORRELATIONS</title><p>Though the ultimate goal of enhancing percutaneous absorption relates to humans, <italic>in vivo</italic> studies are not always possible, for various reasons. Although comparative studies of <italic>in vitro</italic> and <italic>in vivo</italic> absorption through animal models or human skin are limited, the existing data strongly support the relevance of in vitro data.</p><p>The investigations of Karali <italic>et al.</italic> revealed azidothymidine to be delivered systemically from transdermal gel formulation containing carvone at rate of 0.9&#x000a0;mg/cm<sup>2</sup>/24&#x000a0;h in rats. In order to achieve the minimum effective concentration of azidothymidine in humans (0.27&#x000a0;&#x003bc;g/ml), a delivery rate of 1&#x000a0;mg/cm<sup>2</sup>/h from transdermal patch of 25&#x000a0;cm<sup>2</sup> in size was needed. Therefore, these studies demonstrated the inability of carvacrol to achieve the required delivery rate of azidothymidine in humans (<xref ref-type="bibr" rid="CR22">22</xref>). Another investigation, however, demonstrated <italic>in vitro</italic> flux ranging from 1.03 to 1.79&#x000a0;mg/cm<sup>2</sup>/h across rat skin by using hydro alcoholic solutions of various terpenes as permeation enhancers. The magnitude of permeation rates documented in this study show a great promise of terpenes in achieving the required systemic delivery rate of azidothymidine in humans (<xref ref-type="bibr" rid="CR19">19</xref>).</p><p><italic>In vitro</italic> permeation studies of nicorandil across rat abdominal skin from transdermal formulations containing carvone or limonene revealed, respectively, 1.6-fold and 1.7-fold greater permeation than that required for achieving their systemically effective concentration in rats. However, the observed enhancement (1.6-fold) of permeation of nicorandil across rat skin did not seem capable of providing effective plasma concentration in humans due to the higher resistance of human SC, which is three times less permeable than rat skin (<xref ref-type="bibr" rid="CR40">40</xref>,<xref ref-type="bibr" rid="CR89">89</xref>). Nevertheless, using carvone as enhancer and adhesive-coated EVA 2825 membrane, the average steady state of 20.5&#x000a0;ng/ml in humans was maintained through 24&#x000a0;h (<xref ref-type="bibr" rid="CR89">89</xref>). The lag time was observed to reduce to 2.8&#x000a0;h and a steady state plasma concentration of nicorandil was maintained at 21.3&#x000a0;ng/ml through 24&#x000a0;h when limonene was employed as enhancer and adhesive-coated EVA 2825 as rate controlling membrane (<xref ref-type="bibr" rid="CR40">40</xref>).</p><p>The suitability of adhesive-coated EVA 2825 membrane using limonene (<xref ref-type="bibr" rid="CR90">90</xref>) or menthol (<xref ref-type="bibr" rid="CR91">91</xref>) as enhancers for nicardipine hydrochloride was tested by employing excised rat skin. Limonene or menthol enhanced the <italic>in vitro</italic> permeation of nicardipine hydrochloride, respectively, by 2.08-fold and 1.8-fold. The systemic delivery of nicardipine hydrochloride in humans was maintained by limonene or menthol, respectively, at 32.1 or 21.2&#x000a0;ng/ml. Limonene maintained the plasma steady state concentration over 20&#x000a0;h, while menthol maintained it over 26&#x000a0;h. Although, these patches were not evaluated for their effectiveness from pharmacodynamic view point, their ability to maintain constant drug level in plasma of human volunteers suggested sustained systemic drug delivery (<xref ref-type="bibr" rid="CR90">90</xref>,<xref ref-type="bibr" rid="CR91">91</xref>).</p></sec><sec id="Sec10"><title>TERPENES AND THEIR DISPOSITION</title><p>Despite the ubiquitous occurrence and importance of terpenes in food, little is known about their metabolic fate. After ingestion, terpenes are well absorbed and metabolized via hydroxylation or epoxidation by microsomal monooxidases. The primary metabolites are further transformed into more polar compounds and are excreted via urine. Most of the data available pertains to rat (<xref ref-type="bibr" rid="CR92">92</xref>&#x02013;<xref ref-type="bibr" rid="CR95">95</xref>) or rabbits (<xref ref-type="bibr" rid="CR96">96</xref>,<xref ref-type="bibr" rid="CR97">97</xref>) which were fed with terpene rich diets. However, it is not certain that these dispositional characteristics can be extrapolated to humans, particular in view of the relatively large doses administered to animals. Terpene concentration might affect the type of metabolite formed (<xref ref-type="bibr" rid="CR98">98</xref>,<xref ref-type="bibr" rid="CR99">99</xref>).</p><p>Studies on metabolism of monoterpenes, carvone and pulgeon in humans using MICA (Metabolism of Ingestion Correlated Amounts) approach have been carried out. Metabolites formed were identified as &#x003b1;,4-dimethyl-5-oxo-3-cyclohexene-1-acetic acid (dihydrocarvonic acid), &#x003b1;-methylene-4-methyl-5-oxo-3-cyclohexene-1-acetic acid (carvonic acid), and 5-(1,2-dihydroxy-1-methylethyl)-2-methyl-2-cyclohexen-1-one (uroterpenolone) on the basis of mass spectral analysis in combination with synthesis and NMR experiments of the acidic fraction. Minor metabolites were identified as reduction products of carvone, namely, the alcohols carveol and dihydrocarveol. The previously identified major <italic>in vivo</italic> metabolite in rabbits, 10-hydroxycarvone (<xref ref-type="bibr" rid="CR97">97</xref>), could not be detected, indicating either concentration dependent effect or interspecies differences. No differences in metabolism between <italic>S</italic>-(+)- and <italic>R</italic>-(&#x02212;)-carvone were detected (<xref ref-type="bibr" rid="CR100">100</xref>).</p><p>There have been several studies of (<italic>R</italic>)-(+)- and (<italic>S</italic>)-(&#x02212;)-pulegone metabolism in rats (<xref ref-type="bibr" rid="CR99">99</xref>&#x02013;<xref ref-type="bibr" rid="CR103">103</xref>), <italic>ex vivo</italic> experiments with rat liver microsomes (<xref ref-type="bibr" rid="CR104">104</xref>&#x02013;<xref ref-type="bibr" rid="CR107">107</xref>) and human cytochrome <italic>P</italic>450 enzymes (<xref ref-type="bibr" rid="CR108">108</xref>). Engel identified 2-(2-hydroxy-1-methylethyl)-5-methylcyclohexanone (8-hydroxymenthone), 3-hydroxy-3-methyl-6-(1-methylethyl)cyclohexanone (1-hydroxymenthone), 3-methyl-6-(1- ethylethyl)cyclohexanol (menthol), and E-2-(2-hydroxy- 1-methylethylidene)-5-methylcyclohexanone (10-hydroxypulegone) as the four major metabolites of pulegone. 10-hydroxypulegone was identified as a minor metabolite of (<italic>S</italic>)-(&#x02212;)-pulegone. However, it was one of the major metabolites of (<italic>R</italic>)-(+)-pulegone. In addition, 3-methyl-6-(1-methylethyl)-2-cyclohexenone (piperitone,) and R,R,4-trimethyl-1- cyclohexene-1-methanol (3-<italic>p</italic>-menthen-8-ol) were identified as minor metabolites (<xref ref-type="bibr" rid="CR109">109</xref>). Menthofuran was identified early as a metabolite of pulegone formed after ingestion of large amounts of pennyroyal oil (<xref ref-type="bibr" rid="CR110">110</xref>), however it was later found that menthofuran was most probably an artifactual product formed during workup from known (10-hydroxypulegone) and/or unknown precursors. The reaction of 10-hydroxypulegone forming menthofuran is considerably faster in aqueous solution at room temperature at any pH, leading to complete transformation of 10-hydroxypulegone to menthofuran, usually within hours. Therefore, this reaction was considered as a major source of menthofuran. As a consequence, the amount of menthofuran detected in metabolism experiments was strongly dependent on the workup method. The precursor, 10-acetoxypulegone, was also unstable and it slowly isomerized to form 9-acetoxypulegone (<xref ref-type="bibr" rid="CR111">111</xref>). Engel was not able to clarify that <italic>p</italic>-cresol was a major metabolite of menthofuran and, therefore, whether it was responsible for the toxic effects associated with pulegone ingestion. The difference in toxicity between (<italic>S</italic>)-(&#x02212;)- and (<italic>R</italic>)-(+)-pulegone could be explained by the strongly diminished ability for enzymatic reduction of the double bond in (R)-(+)-pulegone, which might lead to further oxidative metabolism of 10-hydroxypulegone and the formation of currently undetected metabolites. These metabolites could possibly account for the observed hepatotoxic and pneumotoxic activity observed in humans (<xref ref-type="bibr" rid="CR109">109</xref>).</p></sec><sec id="Sec11"><title>CONCLUSION</title><p>Terpenes, the naturally occurring volatile oils, appear to be clinically acceptable penetration enhancers as indicated by high percutaneous enhancement ability, reversible effect on the lipids of SC, minimal percutaneous irritancy at low concentration (1&#x02013;5%) and good evidence of freedom from toxicity. Moreover, a variety of terpenes have been shown to increase percutaneous absorption of both hydrophilic and lipophilic drugs when judiciously selected and combined with solvents. Hence, use of terpenes can be expected to yield satisfactory permeation of drugs across skin from transdermal formulations. However, proper selection of terpenes based on the functional groups, log <italic>p</italic> values, metabolic disposition would be important. However, it seems more rationale and essential to actually test the terpene containing formulations in humans in order to arrive at a reliable conclusion regarding systemic efficacy of the transdermal patches.</p></sec></body><back><ref-list id="Bib1"><title>References</title><ref id="CR1"><label>1.</label><mixed-citation publication-type="journal"><person-group person-group-type="author"><name><surname>Kurihara-Bergstrom</surname><given-names>T.</given-names></name><name><surname>Good</surname><given-names>W. R.</given-names></name></person-group><article-title>Skin development and permeability</article-title><source>J. Control. Release</source><year>1987</year><volume>6</volume><fpage>51</fpage><lpage>58</lpage></mixed-citation></ref><ref id="CR2"><label>2.</label><mixed-citation publication-type="journal"><person-group person-group-type="author"><name><surname>Shokri</surname><given-names>J.</given-names></name><name><surname>Nokhodchi</surname><given-names>A.</given-names></name><name><surname>Dashbolaghi</surname><given-names>A.</given-names></name><etal/></person-group><article-title>The effect of surfactants on the skin penetration of diazepam</article-title><source>Int. J. Pharm.</source><year>2001</year><volume>228</volume><fpage>99</fpage><lpage>107</lpage><pub-id pub-id-type="pmid">11576772</pub-id></mixed-citation></ref><ref id="CR3"><label>3.</label><mixed-citation publication-type="journal"><person-group person-group-type="author"><name><surname>Kannikkannan</surname><given-names>N.</given-names></name><name><surname>Kanimalla</surname><given-names>K.</given-names></name><name><surname>Lamba</surname><given-names>S. S.</given-names></name><etal/></person-group><article-title>Structure activity relationship of chemical penetration enhancers in transdermal drug activity</article-title><source>Cur. Med. Chem.</source><year>2003</year><volume>7</volume><fpage>603</fpage><lpage>608</lpage></mixed-citation></ref><ref id="CR4"><label>4.</label><mixed-citation publication-type="journal"><person-group person-group-type="author"><name><surname>Aungst</surname><given-names>B. J.</given-names></name><name><surname>Rogers</surname><given-names>N. J.</given-names></name><name><surname>Shefter</surname><given-names>E.</given-names></name></person-group><article-title>Enhancement of naloxone penetration through human skin in vitro using fatty acids, fatty alcohols, surfactants, sulfoxides and amides</article-title><source>Int. J. Pharm.</source><year>1986</year><volume>3</volume><fpage>225</fpage><lpage>234</lpage></mixed-citation></ref><ref id="CR5"><label>5.</label><mixed-citation publication-type="journal"><person-group person-group-type="author"><name><surname>Okabe</surname><given-names>H.</given-names></name><name><surname>Suzuki</surname><given-names>E.</given-names></name><name><surname>Saitoh</surname><given-names>T.</given-names></name><etal/></person-group><article-title>Development of novel transdermal system containing <italic>d</italic>-limonene and ethanol as absorption enhancers</article-title><source>J. Control. Release</source><year>1994</year><volume>32</volume><fpage>243</fpage><lpage>247</lpage></mixed-citation></ref><ref id="CR6"><label>6.</label><mixed-citation publication-type="journal"><person-group person-group-type="author"><name><surname>Lashmar</surname><given-names>U. T.</given-names></name><name><surname>Hadgraft</surname><given-names>J.</given-names></name><name><surname>Thomas</surname><given-names>N.</given-names></name></person-group><article-title>Topical application of penetration enhancers to the skin of nude mice; a histopathological study</article-title><source>J. Pharm. Pharmacol.</source><year>1989</year><volume>41</volume><fpage>118</fpage><lpage>122</lpage><pub-id pub-id-type="pmid">2568419</pub-id></mixed-citation></ref><ref id="CR7"><label>7.</label><mixed-citation publication-type="journal"><person-group person-group-type="author"><name><surname>Okamoto</surname><given-names>H.</given-names></name><name><surname>Ohyabu</surname><given-names>M.</given-names></name><name><surname>Hashida</surname><given-names>M.</given-names></name><etal/></person-group><article-title>Enhanced penetration of mitomycin C through hairless mouse and rat skin by enhancers with terpene moieties</article-title><source>J. Pharm. Pharmacol.</source><year>1987</year><volume>39</volume><fpage>531</fpage><lpage>534</lpage><pub-id pub-id-type="pmid">2886622</pub-id></mixed-citation></ref><ref id="CR8"><label>8.</label><mixed-citation publication-type="book"><person-group person-group-type="author"><name><surname>Thakur</surname><given-names>R. A.</given-names></name><name><surname>Wang</surname><given-names>Y.</given-names></name><name><surname>Michniak</surname><given-names>B. B.</given-names></name></person-group><person-group person-group-type="editor"><name><surname>Smith</surname><given-names>E. W.</given-names></name><name><surname>Maibach</surname><given-names>H. I.</given-names></name></person-group><article-title>Essential oils and terpenes</article-title><source>Percutaneous Penetration Enhancers</source><year>2006</year><publisher-loc>Boca Raton</publisher-loc><publisher-name>CRC Press</publisher-name><fpage>159</fpage><lpage>173</lpage></mixed-citation></ref><ref id="CR9"><label>9.</label><mixed-citation publication-type="journal"><person-group person-group-type="author"><name><surname>Williams</surname><given-names>A. C.</given-names></name><name><surname>Barry</surname><given-names>B. W.</given-names></name></person-group><article-title>Terpenes and the lipid&#x02013;protein-partitioning theory of skin penetration enhancement</article-title><source>Pharm. Res.</source><year>1991</year><volume>8</volume><fpage>17</fpage><lpage>24</lpage><pub-id pub-id-type="pmid">2014203</pub-id></mixed-citation></ref><ref id="CR10"><label>10.</label><mixed-citation publication-type="other">FDA. Part 182 substances generally recognized as safe. <ext-link ext-link-type="uri" xlink:href="http://www.cfsan.fda.gov/~Ird/fcf182.html">http://www.cfsan.fda.gov/~Ird/fcf182.html</ext-link>. Acessed on Nov 30, 2006.</mixed-citation></ref><ref id="CR11"><label>11.</label><mixed-citation publication-type="journal"><person-group person-group-type="author"><name><surname>Yamane</surname><given-names>M. A.</given-names></name><name><surname>Williams</surname><given-names>A. C.</given-names></name><name><surname>Barry</surname><given-names>B. W.</given-names></name></person-group><article-title>Effects of terpenes and oleic acid as skin penetration enhancers towards 5-fluorouracil as assessed with time; permeation, partitioning and differential scanning calorimetry</article-title><source>Int. J. Pharm.</source><year>1995</year><volume>116</volume><fpage>237</fpage><lpage>251</lpage></mixed-citation></ref><ref id="CR12"><label>12.</label><mixed-citation publication-type="journal"><person-group person-group-type="author"><name><surname>Yamane</surname><given-names>M. A.</given-names></name><name><surname>Williams</surname><given-names>A. C.</given-names></name><name><surname>Barry</surname><given-names>B. W.</given-names></name></person-group><article-title>Terpene penetration enhancers in propylene glycol/water co-solvent systems: Effectiveness and mechanism of action</article-title><source>J. Pharm. Pharmacol.</source><year>1995</year><volume>47</volume><fpage>978</fpage><lpage>989</lpage><pub-id pub-id-type="pmid">8932680</pub-id></mixed-citation></ref><ref id="CR13"><label>13.</label><mixed-citation publication-type="journal"><person-group person-group-type="author"><name><surname>El-Kattan</surname><given-names>A. F.</given-names></name><name><surname>Asbill</surname><given-names>C. S.</given-names></name><name><surname>Kim</surname><given-names>N.</given-names></name><etal/></person-group><article-title>The effects of terpene enhancers on the percutaneous permeation of drugs with different lipophilicities</article-title><source>Int. J. Pharm.</source><year>2001</year><volume>215</volume><fpage>229</fpage><lpage>240</lpage><pub-id pub-id-type="pmid">11250108</pub-id></mixed-citation></ref><ref id="CR14"><label>14.</label><mixed-citation publication-type="journal"><person-group person-group-type="author"><name><surname>Lim</surname><given-names>P. F. C.</given-names></name><name><surname>Liu</surname><given-names>X. Y.</given-names></name><name><surname>Kang</surname><given-names>L.</given-names></name><etal/></person-group><article-title>Limonene GPI/PG organogel as a vehicle in transdermal delivery of haloperidol</article-title><source>Int. J. Pharm.</source><year>2006</year><volume>311</volume><fpage>157</fpage><lpage>164</lpage><pub-id pub-id-type="pmid">16451823</pub-id></mixed-citation></ref><ref id="CR15"><label>15.</label><mixed-citation publication-type="journal"><person-group person-group-type="author"><name><surname>Gonz&#x000e1;lez</surname><given-names>N.</given-names></name><name><surname>Sumano</surname><given-names>H.</given-names></name></person-group><article-title>Design of two liquid ibuprofen-poloxamer-limonene or menthol preparations for dermal administration</article-title><source>Drug Deliv.</source><year>2007</year><volume>14</volume><fpage>287</fpage><lpage>293</lpage><pub-id pub-id-type="pmid">17613016</pub-id></mixed-citation></ref><ref id="CR16"><label>16.</label><mixed-citation publication-type="journal"><person-group person-group-type="author"><name><surname>Tas</surname><given-names>T.</given-names></name><name><surname>Ozkan</surname><given-names>Y.</given-names></name><name><surname>Okyar</surname><given-names>A.</given-names></name><name><surname>Savaser</surname><given-names>A.</given-names></name></person-group><article-title>In vitro and ex vivo permeation studies of etodolac from hydrophilic gels and effect of terpenes as enhancers</article-title><source>Drug Deliv.</source><year>2007</year><volume>14</volume><fpage>453</fpage><lpage>459</lpage><pub-id pub-id-type="pmid">17994363</pub-id></mixed-citation></ref><ref id="CR17"><label>17.</label><mixed-citation publication-type="journal"><person-group person-group-type="author"><name><surname>Vaddi</surname><given-names>H. K.</given-names></name><name><surname>Ho</surname><given-names>P. C.</given-names></name><name><surname>Chan</surname><given-names>Y. W.</given-names></name><etal/></person-group><article-title>Oxide terpenes as human skin penetration enhancers of haloperidol from ethanol and propylene glycol and their modes o action on stratum corneum</article-title><source>Biol. Pharm. Bull.</source><year>2003</year><volume>26</volume><fpage>220</fpage><lpage>228</lpage><pub-id pub-id-type="pmid">12576684</pub-id></mixed-citation></ref><ref id="CR18"><label>18.</label><mixed-citation publication-type="journal"><person-group person-group-type="author"><name><surname>Magnusson</surname><given-names>B. M.</given-names></name><name><surname>Runn</surname><given-names>P.</given-names></name><name><surname>Karlsson</surname><given-names>K.</given-names></name><etal/></person-group><article-title>Terpenes and ethanol enhance the transdermal permeation of the tripeptide thyrotropin releasing hormone in human epidermis</article-title><source>Int. J. Pharm.</source><year>1997</year><volume>157</volume><fpage>113</fpage><lpage>121</lpage></mixed-citation></ref><ref id="CR19"><label>19.</label><mixed-citation publication-type="journal"><person-group person-group-type="author"><name><surname>Narishetty</surname><given-names>S. T. K.</given-names></name><name><surname>Panchagnula</surname><given-names>R.</given-names></name></person-group><article-title>Transdermal delivery of zidovudine: Effect of terpenes and their mechanism of action</article-title><source>J. Control. Release</source><year>2004</year><volume>95</volume><fpage>367</fpage><lpage>379</lpage><pub-id pub-id-type="pmid">15023449</pub-id></mixed-citation></ref><ref id="CR20"><label>20.</label><mixed-citation publication-type="journal"><person-group person-group-type="author"><name><surname>Narishetty</surname><given-names>S. T. K.</given-names></name><name><surname>Panchagnula</surname><given-names>R.</given-names></name></person-group><article-title>Effect of <sc>l</sc>-menthol and 1,8-cineole on phase behavior and molecular organization of SC lipids and skin permeation of zidovudine</article-title><source>J. Control. Release</source><year>2005</year><volume>102</volume><fpage>59</fpage><lpage>70</lpage><pub-id pub-id-type="pmid">15653134</pub-id></mixed-citation></ref><ref id="CR21"><label>21.</label><mixed-citation publication-type="journal"><person-group person-group-type="author"><name><surname>Krishnaiah</surname><given-names>Y. S. R.</given-names></name><name><surname>Satyanarayana</surname><given-names>V.</given-names></name><name><surname>Karthikeyan</surname><given-names>R. S.</given-names></name></person-group><article-title>Penetration enhancing effect of menthol on the percutaneous flux of nicardipine hydrochloride through excised rat epidermis from hydroxypropyl cellulose gels</article-title><source>Pharm. Dev. Tech.</source><year>2002</year><volume>7</volume><fpage>305</fpage><lpage>315</lpage></mixed-citation></ref><ref id="CR22"><label>22.</label><mixed-citation publication-type="journal"><person-group person-group-type="author"><name><surname>Kararli</surname><given-names>T. T.</given-names></name><name><surname>Kirchhoff</surname><given-names>C. F.</given-names></name><name><surname>Penzotti</surname><given-names>S. C.</given-names></name></person-group><article-title>Enhancement of transdermal transport of azidothymidine (AZT) with novel terpene and terpene like enhancers: In vivo&#x02013;in vitro correlations</article-title><source>J. Control. Release</source><year>1995</year><volume>34</volume><fpage>43</fpage><lpage>51</lpage></mixed-citation></ref><ref id="CR23"><label>23.</label><mixed-citation publication-type="journal"><person-group person-group-type="author"><name><surname>Krishnaiah</surname><given-names>Y. S. R.</given-names></name><name><surname>Satyanarayana</surname><given-names>V.</given-names></name><name><surname>Bhaskar</surname><given-names>P.</given-names></name></person-group><article-title>Enhanced percutaneous permeability of nicardipine hydrochloride by carvone across the rat abdominal skin</article-title><source>Drug Dev. Ind. Pharm.</source><year>2003</year><volume>29</volume><fpage>191</fpage><lpage>202</lpage><pub-id pub-id-type="pmid">12648016</pub-id></mixed-citation></ref><ref id="CR24"><label>24.</label><mixed-citation publication-type="journal"><person-group person-group-type="author"><name><surname>Krishnaiah</surname><given-names>Y. S. R.</given-names></name><name><surname>Bhaskar</surname><given-names>P.</given-names></name><name><surname>Satyanarayana</surname><given-names>V.</given-names></name></person-group><article-title>Penetration enhancing effect of ethanol-water solvent system and ethanolic solution of carvone on transdermal permeability of nimodipine from HPMC gel across rat abdominal skin</article-title><source>Pharm. Dev. Tech.</source><year>2004</year><volume>1</volume><fpage>63</fpage><lpage>74</lpage></mixed-citation></ref><ref id="CR25"><label>25.</label><mixed-citation publication-type="journal"><person-group person-group-type="author"><name><surname>Nokhodchi</surname><given-names>A.</given-names></name><name><surname>Sharabiani</surname><given-names>K.</given-names></name><name><surname>Rashidi</surname><given-names>M. R.</given-names></name><etal/></person-group><article-title>The effect of terpene concentrations on the skin penetration of diclofenac sodium</article-title><source>Int. J. Pharm.</source><year>2007</year><volume>335</volume><fpage>97</fpage><lpage>105</lpage><pub-id pub-id-type="pmid">17174049</pub-id></mixed-citation></ref><ref id="CR26"><label>26.</label><mixed-citation publication-type="journal"><person-group person-group-type="author"><name><surname>Vaddi</surname><given-names>H. K.</given-names></name><name><surname>Ho</surname><given-names>P. C.</given-names></name><name><surname>Chan</surname><given-names>Y. W.</given-names></name><etal/></person-group><article-title>Terpenes in ethanol: Haloperidol permeation and partition through human skin and stratum corneum changes</article-title><source>J. Control. Release</source><year>2002</year><volume>81</volume><fpage>121</fpage><lpage>133</lpage><pub-id pub-id-type="pmid">11992685</pub-id></mixed-citation></ref><ref id="CR27"><label>27.</label><mixed-citation publication-type="journal"><person-group person-group-type="author"><name><surname>Vaddi</surname><given-names>H. K.</given-names></name><name><surname>Ho</surname><given-names>P. C.</given-names></name><name><surname>Chan</surname><given-names>S. Y.</given-names></name></person-group><article-title>Terpenes in propylene glycol as skin-penetration enhancers: permeation and partition of haloperidol, Fourier transform infrared spectroscopy, and differential scanning calorimetry</article-title><source>J. PharmSci.</source><year>2002</year><volume>91</volume><fpage>639</fpage><lpage>1651</lpage></mixed-citation></ref><ref id="CR28"><label>28.</label><mixed-citation publication-type="journal"><person-group person-group-type="author"><name><surname>Duzee</surname><given-names>B. F.</given-names></name></person-group><article-title>Thermal analysis of human stratum corneum</article-title><source>J. Invest. Dermatol.</source><year>1975</year><volume>65</volume><fpage>404</fpage><lpage>408</lpage><pub-id pub-id-type="pmid">1176792</pub-id></mixed-citation></ref><ref id="CR29"><label>29.</label><mixed-citation publication-type="journal"><person-group person-group-type="author"><name><surname>Golden</surname><given-names>G. M.</given-names></name><name><surname>Guzek</surname><given-names>D. B.</given-names></name><name><surname>Harris</surname><given-names>R. R.</given-names></name><etal/></person-group><article-title>Lipid thermotropic transitions in human stratum corneum</article-title><source>J. Invest. Dermatol.</source><year>1986</year><volume>86</volume><fpage>255</fpage><lpage>259</lpage><pub-id pub-id-type="pmid">3745950</pub-id></mixed-citation></ref><ref id="CR30"><label>30.</label><mixed-citation publication-type="journal"><person-group person-group-type="author"><name><surname>Zhao</surname><given-names>K.</given-names></name><name><surname>Singh</surname><given-names>J.</given-names></name></person-group><article-title>Mechanisms of percutaneous absorption of tamoxifen by terpenes: Eugenol, <italic>d</italic>-limonene and menthone</article-title><source>J. Control. Release</source><year>1998</year><volume>55</volume><fpage>253</fpage><lpage>260</lpage><pub-id pub-id-type="pmid">9795076</pub-id></mixed-citation></ref><ref id="CR31"><label>31.</label><mixed-citation publication-type="journal"><person-group person-group-type="author"><name><surname>Pillai</surname><given-names>O.</given-names></name><name><surname>Panchagnula</surname><given-names>R.</given-names></name></person-group><article-title>Transdermal iontophoresis of insulin V. Effect of terpenes</article-title><source>J. Control. Release</source><year>2003</year><volume>88</volume><fpage>287</fpage><lpage>296</lpage><pub-id pub-id-type="pmid">12628335</pub-id></mixed-citation></ref><ref id="CR32"><label>32.</label><mixed-citation publication-type="journal"><person-group person-group-type="author"><name><surname>Knutson</surname><given-names>K.</given-names></name><name><surname>Potts</surname><given-names>R. O.</given-names></name><name><surname>Guzek</surname><given-names>D. B.</given-names></name><etal/></person-group><article-title>Macro and molecular physical chemical considerations in understanding drug transport in the stratum corneum</article-title><source>J. Control. Release</source><year>1985</year><volume>2</volume><fpage>67</fpage><lpage>87</lpage></mixed-citation></ref><ref id="CR33"><label>33.</label><mixed-citation publication-type="book"><person-group person-group-type="author"><name><surname>Tori</surname><given-names>H.</given-names></name><name><surname>Tasumi</surname><given-names>M.</given-names></name></person-group><person-group person-group-type="editor"><name><surname>Mantsch</surname><given-names>H. H.</given-names></name><name><surname>Chapman</surname><given-names>D.</given-names></name></person-group><article-title>Theoretical analyses of the amide I infrared bands of globular proteins</article-title><source>Infrared Spectroscopy of Biomolecules</source><year>1996</year><publisher-loc>New York</publisher-loc><publisher-name>Wiley-Liss</publisher-name><fpage>1</fpage><lpage>18</lpage></mixed-citation></ref><ref id="CR34"><label>34.</label><mixed-citation publication-type="book"><person-group person-group-type="author"><name><surname>Norman Grainger</surname><given-names>B.</given-names></name><name><surname>Max</surname><given-names>W.</given-names></name></person-group><source>Herbal Drugs and Phytopharmaceuticals, A Handbook for Practice on a Scientific Basis with Reference to German Commission E Monographs</source><year>2001</year><edition>2</edition><publisher-loc>New York</publisher-loc><publisher-name> CRC Press</publisher-name></mixed-citation></ref><ref id="CR35"><label>35.</label><mixed-citation publication-type="journal"><person-group person-group-type="author"><name><surname>Monti</surname><given-names>D.</given-names></name><name><surname>Chetoni</surname><given-names>P.</given-names></name><name><surname>Burgalassi</surname><given-names>S.</given-names></name><etal/></person-group><article-title>Effect of different terpene containing essential oils on permeation of estradiol through hairless mouse skin</article-title><source>Int. J. Pharm.</source><year>2002</year><volume>237</volume><fpage>209</fpage><lpage>214</lpage><pub-id pub-id-type="pmid">11955818</pub-id></mixed-citation></ref><ref id="CR36"><label>36.</label><mixed-citation publication-type="journal"><person-group person-group-type="author"><name><surname>Okabe</surname><given-names>H.</given-names></name><name><surname>Takayama</surname><given-names>K.</given-names></name><name><surname>Nagai</surname><given-names>T.</given-names></name><etal/></person-group><article-title>Effect of <italic>d</italic>-limonene and related compounds on the percutaneous absorption of indomethacin</article-title><source>Drug Des. Deliv.</source><year>1989</year><volume>4</volume><fpage>313</fpage><lpage>321</lpage><pub-id pub-id-type="pmid">2775451</pub-id></mixed-citation></ref><ref id="CR37"><label>37.</label><mixed-citation publication-type="journal"><person-group person-group-type="author"><name><surname>Kikuchi</surname><given-names>K.</given-names></name><name><surname>Takayama</surname><given-names>K.</given-names></name><name><surname>Nagai</surname><given-names>T.</given-names></name></person-group><article-title>Effect of <italic>d</italic>-limonene on the amounts of ethanol and indomethacin penetrated from aqueous gel ointment to rat skin</article-title><source>Chem. Pharm. Bull.</source><year>1992</year><volume>40</volume><fpage>3108</fpage><lpage>3109</lpage><pub-id pub-id-type="pmid">1477929</pub-id></mixed-citation></ref><ref id="CR38"><label>38.</label><mixed-citation publication-type="journal"><person-group person-group-type="author"><name><surname>Okabe</surname><given-names>H.</given-names></name><name><surname>Takayama</surname><given-names>K.</given-names></name><name><surname>Nagai</surname><given-names>T.</given-names></name></person-group><article-title>Percutaneous absorption of ketoprofen from acrylic gels patches containing <italic>d</italic>-limonene and ethanol as absorption enhancers</article-title><source>Chem. Pharm. Bull.</source><year>1992</year><volume>40</volume><fpage>1906</fpage><lpage>1910</lpage><pub-id pub-id-type="pmid">1394713</pub-id></mixed-citation></ref><ref id="CR39"><label>39.</label><mixed-citation publication-type="journal"><person-group person-group-type="author"><name><surname>Ohara</surname><given-names>N.</given-names></name><name><surname>Takayama</surname><given-names>K.</given-names></name><name><surname>Machida</surname><given-names>Y.</given-names></name><etal/></person-group><article-title>Combined effect of <italic>d</italic>-limonene and temperature on the skin permeation of ketoprofen</article-title><source>Int. J. Pharm.</source><year>1994</year><volume>105</volume><fpage>31</fpage><lpage>38</lpage></mixed-citation></ref><ref id="CR40"><label>40.</label><mixed-citation publication-type="journal"><person-group person-group-type="author"><name><surname>Krishnaiah</surname><given-names>Y. S. R.</given-names></name><name><surname>Chandrasekhar</surname><given-names>D. V.</given-names></name><name><surname>Rama</surname><given-names>B.</given-names></name><etal/></person-group><article-title>In vivo evaluation of limonene based transdermal therapeutic system of nicorandil in healthy human volunteers</article-title><source>Skin Pharmacol. Physiol.</source><year>2005</year><volume>18</volume><fpage>263</fpage><lpage>272</lpage><pub-id pub-id-type="pmid">16113596</pub-id></mixed-citation></ref><ref id="CR41"><label>41.</label><mixed-citation publication-type="journal"><person-group person-group-type="author"><name><surname>Hori</surname><given-names>M.</given-names></name><name><surname>Satoh</surname><given-names>S.</given-names></name><name><surname>Maibach</surname><given-names>H. I.</given-names></name><etal/></person-group><article-title>Enhancement of propranolol hydrochloride and diazepam skin absorption in vitro: Effect of enhancer lipophilicity</article-title><source>J. Pharm. Sci.</source><year>1991</year><volume>80</volume><fpage>32</fpage><lpage>35</lpage><pub-id pub-id-type="pmid">2013847</pub-id></mixed-citation></ref><ref id="CR42"><label>42.</label><mixed-citation publication-type="journal"><person-group person-group-type="author"><name><surname>Moghimi</surname><given-names>H.</given-names></name><name><surname>Williams</surname><given-names>A.</given-names></name><name><surname>Barry</surname><given-names>B.</given-names></name></person-group><article-title>A lamellar matrix model for stratum corneum intercellular lipids. V. Effects of terpene penetration enhancers on the structure and thermal behavior of the matrix</article-title><source>Int. J. Pharm.</source><year>1997</year><volume>146</volume><fpage>41</fpage><lpage>54</lpage></mixed-citation></ref><ref id="CR43"><label>43.</label><mixed-citation publication-type="journal"><person-group person-group-type="author"><name><surname>Okabe</surname><given-names>H.</given-names></name><name><surname>Obata</surname><given-names>Y.</given-names></name><name><surname>Takayama</surname><given-names>K.</given-names></name><etal/></person-group><article-title>Percutaneous absorption enhancing effect and skin irritation of monocyclic monoterpenes</article-title><source>Drug Des. Del.</source><year>1990</year><volume>6</volume><fpage>229</fpage><lpage>238</lpage></mixed-citation></ref><ref id="CR44"><label>44.</label><mixed-citation publication-type="journal"><person-group person-group-type="author"><name><surname>Lee</surname><given-names>C. K.</given-names></name><name><surname>Uchida</surname><given-names>T.</given-names></name><name><surname>Kitagawa</surname><given-names>K.</given-names></name><etal/></person-group><article-title>Effect of hydrophilic and lipophilic vehicles on skin permeation of tegafur, alclofenac and ibuprofen with or without permeation enhancers</article-title><source>Biol. Pharm. Bull.</source><year>1993</year><volume>16</volume><fpage>1264</fpage><lpage>1269</lpage><pub-id pub-id-type="pmid">7907514</pub-id></mixed-citation></ref><ref id="CR45"><label>45.</label><mixed-citation publication-type="journal"><person-group person-group-type="author"><name><surname>Lee</surname><given-names>C. K.</given-names></name><name><surname>Uchida</surname><given-names>T.</given-names></name><name><surname>Kitagawa</surname><given-names>K.</given-names></name><etal/></person-group><article-title>Skin permeability of various drugs with different lipophilicity</article-title><source>J. Pharm. Sci.</source><year>1994</year><volume>83</volume><fpage>562</fpage><lpage>565</lpage><pub-id pub-id-type="pmid">8046615</pub-id></mixed-citation></ref><ref id="CR46"><label>46.</label><mixed-citation publication-type="journal"><person-group person-group-type="author"><name><surname>Phillips</surname><given-names>C. A.</given-names></name><name><surname>Michniak</surname><given-names>B. B.</given-names></name></person-group><article-title>Transdermal delivery of drugs with differing lipophilicities using azone analogs as dermal penetration enhancers</article-title><source>J. Pharm. Sci.</source><year>1995</year><volume>84</volume><fpage>1427</fpage><lpage>1433</lpage><pub-id pub-id-type="pmid">8748324</pub-id></mixed-citation></ref><ref id="CR47"><label>47.</label><mixed-citation publication-type="journal"><person-group person-group-type="author"><name><surname>Borrras-Blasco</surname><given-names>J.</given-names></name><name><surname>Lopez</surname><given-names>A.</given-names></name><name><surname>Morant</surname><given-names>M.</given-names></name><etal/></person-group><article-title>Influence of sodium lauryl sulfate on in vitro percutaneous absorption of compounds with different lipophilicity</article-title><source>Eur. J. Pharm. Sci.</source><year>1997</year><volume>5</volume><fpage>15</fpage><lpage>22</lpage></mixed-citation></ref><ref id="CR48"><label>48.</label><mixed-citation publication-type="journal"><person-group person-group-type="author"><name><surname>Godwin</surname><given-names>D. A.</given-names></name><name><surname>Michniak</surname><given-names>B. B.</given-names></name></person-group><article-title>Influence of drug lipophilicity on terpenes as transdermal penetration enhancers</article-title><source>Drug Dev. Ind. Pharm.</source><year>1999</year><volume>25</volume><fpage>905</fpage><lpage>915</lpage><pub-id pub-id-type="pmid">10434134</pub-id></mixed-citation></ref><ref id="CR49"><label>49.</label><mixed-citation publication-type="journal"><person-group person-group-type="author"><name><surname>El-Kattan</surname><given-names>A. F.</given-names></name><name><surname>Asbill</surname><given-names>C. S.</given-names></name><name><surname>Kim</surname><given-names>N.</given-names></name><etal/></person-group><article-title>The effects of terpene enhancer lipophilicity on the percutaneous permeation of hydrocortisone formulated in HPMC gel systems</article-title><source>Int. J. Pharm.</source><year>2000</year><volume>198</volume><fpage>179</fpage><lpage>199</lpage><pub-id pub-id-type="pmid">10767567</pub-id></mixed-citation></ref><ref id="CR50"><label>50.</label><mixed-citation publication-type="journal"><person-group person-group-type="author"><name><surname>Sung</surname><given-names>K. C.</given-names></name><name><surname>Fang</surname><given-names>J.</given-names></name><name><surname>Yoa-Pu</surname><given-names>H. O.</given-names></name></person-group><article-title>Delivery of nalbuphine and its prodrugs across skin by passive diffusion and iontophoresis</article-title><source>J. Control. Release</source><year>2000</year><volume>67</volume><fpage>1</fpage><lpage>8</lpage><pub-id pub-id-type="pmid">10773323</pub-id></mixed-citation></ref><ref id="CR51"><label>51.</label><mixed-citation publication-type="journal"><person-group person-group-type="author"><name><surname>Heard</surname><given-names>C. M.</given-names></name><name><surname>Kung</surname><given-names>D.</given-names></name><name><surname>Thomas</surname><given-names>C. P.</given-names></name></person-group><article-title>Skin penetration enhancement of mefenamic acid by ethanol and 1,8-cineole can be explained by the &#x02018;pull&#x02019; effect</article-title><source>Int. J. Pharm.</source><year>2006</year><volume>321</volume><fpage>167</fpage><lpage>170</lpage><pub-id pub-id-type="pmid">16787720</pub-id></mixed-citation></ref><ref id="CR52"><label>52.</label><mixed-citation publication-type="journal"><person-group person-group-type="author"><name><surname>Anjos</surname><given-names>J. L. V.</given-names></name><name><surname>Neto</surname><given-names>D. S.</given-names></name><name><surname>Alonso</surname><given-names>A.</given-names></name></person-group><article-title>Effects of ethanol/<italic>l</italic>-menthol on the dynamics and partitioning of spin-labeled lipids in the stratum corneum</article-title><source>Eur. J. Pharm. Biopharm.</source><year>2007</year><volume>67</volume><fpage>406</fpage><lpage>412</lpage><pub-id pub-id-type="pmid">17350812</pub-id></mixed-citation></ref><ref id="CR53"><label>53.</label><mixed-citation publication-type="journal"><person-group person-group-type="author"><name><surname>Kaplun-Frischoff</surname><given-names>Y.</given-names></name><name><surname>Touitou</surname><given-names>E.</given-names></name></person-group><article-title>Testosterone skin permeation enhancement by menthol through formation of eutectic with drug and interaction with skin lipids</article-title><source>Eur. J. Pharm. Sci.</source><year>1997</year><volume>86</volume><fpage>1394</fpage><lpage>1399</lpage></mixed-citation></ref><ref id="CR54"><label>54.</label><mixed-citation publication-type="journal"><person-group person-group-type="author"><name><surname>Kunta</surname><given-names>J. R.</given-names></name><name><surname>Goskonda</surname><given-names>V. R.</given-names></name><name><surname>Brotherton</surname><given-names>H. O.</given-names></name><name><surname>Khan</surname><given-names>M. A.</given-names></name><name><surname>Reddy</surname><given-names>I. K.</given-names></name></person-group><article-title>Effect of menthol and related terpenes on the percutaneous absorption of propranolol across excised hairless mouse skin</article-title><source>J. Pharm. Sci.</source><year>1997</year><volume>86</volume><fpage>1369</fpage><lpage>1373</lpage><pub-id pub-id-type="pmid">9423148</pub-id></mixed-citation></ref><ref id="CR55"><label>55.</label><mixed-citation publication-type="journal"><person-group person-group-type="author"><name><surname>Kitagawa</surname><given-names>S.</given-names></name><name><surname>Li</surname><given-names>H.</given-names></name><name><surname>Sato</surname><given-names>S.</given-names></name></person-group><article-title>Skin permeation of parabens in excised guinea pig dorsal skin, its modification by penetration enhancers and their relationship with n-octanol/water partition coefficients</article-title><source>Chem. Pharm. Bull.</source><year>1997</year><volume>45</volume><fpage>1354</fpage><lpage>1357</lpage><pub-id pub-id-type="pmid">9301035</pub-id></mixed-citation></ref><ref id="CR56"><label>56.</label><mixed-citation publication-type="journal"><person-group person-group-type="author"><name><surname>Kobayashi</surname><given-names>D.</given-names></name><name><surname>Matsuzawa</surname><given-names>T.</given-names></name><name><surname>Sugibayashi</surname><given-names>K.</given-names></name><etal/></person-group><article-title>Analysis of the combined effect of 1-menthol and ethanol as skin permeation enhancers based on a two-layer skin model</article-title><source>Pharm. Res.</source><year>1994</year><volume>11</volume><fpage>96</fpage><lpage>103</lpage><pub-id pub-id-type="pmid">8140061</pub-id></mixed-citation></ref><ref id="CR57"><label>57.</label><mixed-citation publication-type="journal"><person-group person-group-type="author"><name><surname>Maitani</surname><given-names>Y.</given-names></name><name><surname>Shimada</surname><given-names>K.</given-names></name><name><surname>Nagai</surname><given-names>T.</given-names></name></person-group><article-title><italic>l</italic>-Menthol, oleic acid and lauricidin in absorption enhancement of free and sodium salt of diclofenac using ethanol treated silicone membrane as model for skin</article-title><source>Chem. Pharm. Bull.</source><year>1996</year><volume>44</volume><fpage>403</fpage><lpage>408</lpage><pub-id pub-id-type="pmid">8998843</pub-id></mixed-citation></ref><ref id="CR58"><label>58.</label><mixed-citation publication-type="journal"><person-group person-group-type="author"><name><surname>Chang</surname><given-names>J. S.</given-names></name><name><surname>Tsai</surname><given-names>Y. H.</given-names></name><name><surname>Wu</surname><given-names>P. C.</given-names></name><etal/></person-group><article-title>Effects of ethanol/<italic>l</italic>-menthol on the dynamics and partitioning of spin-labeled lipids in the stratum corneum</article-title><source>Eur. J. Pharm. Biopharm.</source><year>2007</year><volume>67</volume><fpage>406</fpage><lpage>412</lpage><pub-id pub-id-type="pmid">17350812</pub-id></mixed-citation></ref><ref id="CR59"><label>59.</label><mixed-citation publication-type="journal"><person-group person-group-type="author"><name><surname>Anjos</surname><given-names>J. L. V.</given-names></name><name><surname>Neto</surname><given-names>D. S.</given-names></name><name><surname>Alonso</surname><given-names>A.</given-names></name></person-group><article-title>Effects of 1,8-cineole on the dynamics of lipids and proteins of stratum corneum</article-title><source>Int. J. Pharm.</source><year>2007</year><volume>345</volume><fpage>81</fpage><lpage>87</lpage><pub-id pub-id-type="pmid">17600646</pub-id></mixed-citation></ref><ref id="CR60"><label>60.</label><mixed-citation publication-type="journal"><person-group person-group-type="author"><name><surname>Prasad</surname><given-names>R.</given-names></name><name><surname>Koul</surname><given-names>V.</given-names></name><name><surname>Anand</surname><given-names>S.</given-names></name><name><surname>Khar</surname><given-names>R. K.</given-names></name></person-group><article-title>Effect of DC/mDC iontophoresis and terpenes on transdermal permeation of methotrexate: <italic>In vitro</italic> study</article-title><source>Int. J. Pharm.</source><year>2007</year><volume>333</volume><fpage>70</fpage><lpage>78</lpage><pub-id pub-id-type="pmid">17116378</pub-id></mixed-citation></ref><ref id="CR61"><label>61.</label><mixed-citation publication-type="journal"><person-group person-group-type="author"><name><surname>Negishi</surname><given-names>J.</given-names></name><name><surname>Takayama</surname><given-names>K.</given-names></name><name><surname>Higashiyama</surname><given-names>Y.</given-names></name><etal/></person-group><article-title>Promoting effect of <italic>O</italic>-alkylmenthol and <italic>O</italic>-acylmenthol derivatives on the percutaneous absorption of ketoprofen in rats</article-title><source>STP Pharma. Sci.</source><year>1995</year><volume>5</volume><fpage>156</fpage><lpage>164</lpage></mixed-citation></ref><ref id="CR62"><label>62.</label><mixed-citation publication-type="journal"><person-group person-group-type="author"><name><surname>Nakamura</surname><given-names>Y.</given-names></name><name><surname>Takayama</surname><given-names>K.</given-names></name><name><surname>Higashiyama</surname><given-names>K.</given-names></name><etal/></person-group><article-title>Promoting effect of <italic>O</italic>-ethylmenthol on the percutaneous absorption of ketoprofen</article-title><source>Int. J. Pharm.</source><year>1996</year><volume>145</volume><fpage>29</fpage><lpage>36</lpage></mixed-citation></ref><ref id="CR63"><label>63.</label><mixed-citation publication-type="journal"><person-group person-group-type="author"><name><surname>Obata</surname><given-names>Y.</given-names></name><name><surname>Li</surname><given-names>C. J.</given-names></name><name><surname>Fujikawa</surname><given-names>M.</given-names></name><etal/></person-group><article-title>Evaluation of structure activity relationship of synthesized cyclohexanol derivatives on percutaneous absorption of ketoprofen using artificial neural network</article-title><source>Int. J. Pharm.</source><year>2001</year><volume>212</volume><fpage>223</fpage><lpage>231</lpage><pub-id pub-id-type="pmid">11165080</pub-id></mixed-citation></ref><ref id="CR64"><label>64.</label><mixed-citation publication-type="journal"><person-group person-group-type="author"><name><surname>Obata</surname><given-names>Y.</given-names></name><name><surname>Maruyama</surname><given-names>Y.</given-names></name><name><surname>Takayama</surname><given-names>K.</given-names></name></person-group><article-title>The mode of promoting activity of <italic>O</italic>-ethylmenthol as a transdermal absorption enhancer</article-title><source>Pharm. Res.</source><year>2006</year><volume>23</volume><fpage>392</fpage><lpage>400</lpage><pub-id pub-id-type="pmid">16467993</pub-id></mixed-citation></ref><ref id="CR65"><label>65.</label><mixed-citation publication-type="journal"><person-group person-group-type="author"><name><surname>Cornwell</surname><given-names>P.</given-names></name><name><surname>Barry</surname><given-names>B. W.</given-names></name></person-group><article-title>Sesquiterpene components of volatile oils as skin penetration enhancers for the hydrophilic permeant 5-fluorouracil</article-title><source>J. Pharm. Pharmacol.</source><year>1991</year><volume>46</volume><fpage>261</fpage><lpage>269</lpage><pub-id pub-id-type="pmid">8051608</pub-id></mixed-citation></ref><ref id="CR66"><label>66.</label><mixed-citation publication-type="journal"><person-group person-group-type="author"><name><surname>Arellano</surname><given-names>A.</given-names></name><name><surname>Santoyo</surname><given-names>S.</given-names></name><name><surname>Martin</surname><given-names>C.</given-names></name><etal/></person-group><article-title>Enhancing effect of terpenes on the in vitro percutaneous absorption of diclofenac sodium</article-title><source>Int. J. Pharm.</source><year>1996</year><volume>130</volume><fpage>141</fpage><lpage>145</lpage></mixed-citation></ref><ref id="CR67"><label>67.</label><mixed-citation publication-type="journal"><person-group person-group-type="author"><name><surname>Cornwell</surname><given-names>P.</given-names></name><name><surname>Barry</surname><given-names>B. W.</given-names></name><name><surname>Stoddart</surname><given-names>C. P.</given-names></name><etal/></person-group><article-title>Wide angle X-ray diffraction of human stratum corneum: Effects of hydration and terpene enhancer treatment</article-title><source>J. Pharm. Pharmacol.</source><year>1994</year><volume>46</volume><fpage>938</fpage><lpage>950</lpage><pub-id pub-id-type="pmid">7536240</pub-id></mixed-citation></ref><ref id="CR68"><label>68.</label><mixed-citation publication-type="journal"><person-group person-group-type="author"><name><surname>Xiong</surname><given-names>G. L.</given-names></name><name><surname>Quan</surname><given-names>D.</given-names></name><name><surname>Maibach</surname><given-names>H. I.</given-names></name></person-group><article-title>Effects of penetration enhancers on <italic>in vitro</italic> percutaneous absorption of low molecular weight heparin through human skin</article-title><source>J. Control. Release</source><year>1996</year><volume>42</volume><fpage>289</fpage><lpage>296</lpage></mixed-citation></ref><ref id="CR69"><label>69.</label><mixed-citation publication-type="journal"><person-group person-group-type="author"><name><surname>Kadir</surname><given-names>R.</given-names></name><name><surname>Barry</surname><given-names>B. W.</given-names></name></person-group><article-title>a-Bisabolol, a possible safe penetration enhancer for dermal and transdermal therapeutics</article-title><source>Int. J. Pharm.</source><year>1991</year><volume>70</volume><fpage>87</fpage><lpage>94</lpage></mixed-citation></ref><ref id="CR70"><label>70.</label><mixed-citation publication-type="journal"><person-group person-group-type="author"><name><surname>Yamashita</surname><given-names>F.</given-names></name><name><surname>Hashida</surname><given-names>M.</given-names></name></person-group><article-title>Mechanistic and empirical modeling of skin permeation of drugs</article-title><source>Adv. Drug. Deliv. Rev.</source><year>2003</year><volume>55</volume><fpage>1185</fpage><lpage>1199</lpage><pub-id pub-id-type="pmid">12954198</pub-id></mixed-citation></ref><ref id="CR71"><label>71.</label><mixed-citation publication-type="book"><person-group person-group-type="author"><name><surname>Flynn</surname><given-names>G. L.</given-names></name></person-group><person-group person-group-type="editor"><name><surname>Gerrity</surname><given-names>T.</given-names></name><name><surname>Henry</surname><given-names>C.</given-names></name></person-group><article-title>Physicochemical determinants of skin absorption</article-title><source>Principles of Route-to-Route Extrapolation for Risk Assessment</source><year>1990</year><publisher-loc>New York</publisher-loc><publisher-name>Elsevier</publisher-name><fpage>93</fpage><lpage>127</lpage></mixed-citation></ref><ref id="CR72"><label>72.</label><mixed-citation publication-type="journal"><person-group person-group-type="author"><name><surname>Tayar</surname><given-names>N. E.</given-names></name><name><surname>Tsai</surname><given-names>R. S.</given-names></name><name><surname>Testa</surname><given-names>B.</given-names></name><etal/></person-group><article-title>Percutaneous penetration of drugs: A quantitative structure-permeability relationship study</article-title><source>J. Pharm. Sci.</source><year>1991</year><volume>80</volume><fpage>744</fpage><lpage>749</lpage><pub-id pub-id-type="pmid">1791533</pub-id></mixed-citation></ref><ref id="CR73"><label>73.</label><mixed-citation publication-type="journal"><person-group person-group-type="author"><name><surname>Potts</surname><given-names>R. O.</given-names></name><name><surname>Guy</surname><given-names>R. H.</given-names></name></person-group><article-title>Predicting skin permeability</article-title><source>Pharm. Res.</source><year>1992</year><volume>9</volume><fpage>663</fpage><lpage>669</lpage><pub-id pub-id-type="pmid">1608900</pub-id></mixed-citation></ref><ref id="CR74"><label>74.</label><mixed-citation publication-type="journal"><person-group person-group-type="author"><name><surname>Potts</surname><given-names>R. O.</given-names></name><name><surname>Guy</surname><given-names>R. H.</given-names></name></person-group><article-title>A predictive algorithm for skin permeability: The effects of molecular size and hydrogen bond activity</article-title><source>Pharm. Res.</source><year>1995</year><volume>12</volume><fpage>1628</fpage><lpage>1633</lpage><pub-id pub-id-type="pmid">8592661</pub-id></mixed-citation></ref><ref id="CR75"><label>75.</label><mixed-citation publication-type="journal"><person-group person-group-type="author"><name><surname>Lien</surname><given-names>E. J.</given-names></name><name><surname>Gao</surname><given-names>H.</given-names></name></person-group><article-title>QSAR analysis of skin permeability of various drugs in man as compared to <italic>in vivo</italic> and <italic>in vitro</italic> studies in rodents</article-title><source>Pharm. Res.</source><year>1995</year><volume>12</volume><fpage>583</fpage><lpage>587</lpage><pub-id pub-id-type="pmid">7596996</pub-id></mixed-citation></ref><ref id="CR76"><label>76.</label><mixed-citation publication-type="journal"><person-group person-group-type="author"><name><surname>Cronin</surname><given-names>M. T.</given-names></name><name><surname>Dearden</surname><given-names>J. C.</given-names></name><name><surname>Moss</surname><given-names>G. P.</given-names></name><etal/></person-group><article-title>Investigation of the mechanism of flux across human skin <italic>in vitro</italic> by quantitative structure&#x02013;permeability relationships</article-title><source>Eur. J. Pharm. Sci.</source><year>1999</year><volume>7</volume><fpage>325</fpage><lpage>330</lpage><pub-id pub-id-type="pmid">9971916</pub-id></mixed-citation></ref><ref id="CR77"><label>77.</label><mixed-citation publication-type="journal"><person-group person-group-type="author"><name><surname>Moss</surname><given-names>G. P.</given-names></name><name><surname>Dearden</surname><given-names>J. C.</given-names></name><name><surname>Patel</surname><given-names>H.</given-names></name><etal/></person-group><article-title>Quantitative structure permeability relationships (QSPRs) for percutaneous absorption</article-title><source>Toxicol. In Vitro</source><year>2002</year><volume>16</volume><fpage>299</fpage><lpage>317</lpage><pub-id pub-id-type="pmid">12020604</pub-id></mixed-citation></ref><ref id="CR78"><label>78.</label><mixed-citation publication-type="journal"><person-group person-group-type="author"><name><surname>Geinoz</surname><given-names>S.</given-names></name><name><surname>Rey</surname><given-names>S.</given-names></name><name><surname>Boss</surname><given-names>G.</given-names></name><etal/></person-group><article-title>Quantitative structure-permeation relationships for solute transport across silicone membranes</article-title><source>Pharm. Res.</source><year>2002</year><volume>19</volume><fpage>1622</fpage><lpage>629</lpage><pub-id pub-id-type="pmid">12458667</pub-id></mixed-citation></ref><ref id="CR79"><label>79.</label><mixed-citation publication-type="journal"><person-group person-group-type="author"><name><surname>Fujiwara</surname><given-names>S.</given-names></name><name><surname>Yamashita</surname><given-names>F.</given-names></name><name><surname>Hashida</surname><given-names>M.</given-names></name></person-group><article-title>QSAR analysis of interstudy variable skin permeability based on the &#x0201c;latent membrane permeability&#x0201d; concept</article-title><source>J. Pharm. Sci.</source><year>2003</year><volume>92</volume><fpage>1939</fpage><lpage>1946</lpage><pub-id pub-id-type="pmid">14502534</pub-id></mixed-citation></ref><ref id="CR80"><label>80.</label><mixed-citation publication-type="journal"><person-group person-group-type="author"><name><surname>Katritzky</surname><given-names>A. R.</given-names></name><name><surname>Dobchev</surname><given-names>D. A.</given-names></name><name><surname>Fara</surname><given-names>D. C.</given-names></name><etal/></person-group><article-title>Skin permeation rate as a function of chemical structure</article-title><source>J. Med. Chem.</source><year>2006</year><volume>49</volume><fpage>3305</fpage><lpage>3314</lpage><pub-id pub-id-type="pmid">16722649</pub-id></mixed-citation></ref><ref id="CR81"><label>81.</label><mixed-citation publication-type="journal"><person-group person-group-type="author"><name><surname>Degim</surname><given-names>I. T.</given-names></name></person-group><article-title>New tools and approaches for predicting skin permeability</article-title><source>Drug Discov. Today</source><year>2006</year><volume>11</volume><fpage>517</fpage><lpage>523</lpage><pub-id pub-id-type="pmid">16713903</pub-id></mixed-citation></ref><ref id="CR82"><label>82.</label><mixed-citation publication-type="journal"><person-group person-group-type="author"><name><surname>Neumann</surname><given-names>D.</given-names></name><name><surname>Kohlbacher</surname><given-names>O.</given-names></name><name><surname>Merkwirth</surname><given-names>C.</given-names></name><etal/></person-group><article-title>A fully computational model for predicting percutaneous drug absorption</article-title><source>J. Chem. Inf. Model.</source><year>2006</year><volume>46</volume><fpage>424</fpage><lpage>429</lpage><pub-id pub-id-type="pmid">16426076</pub-id></mixed-citation></ref><ref id="CR83"><label>83.</label><mixed-citation publication-type="journal"><person-group person-group-type="author"><name><surname>Ghafourian</surname><given-names>T.</given-names></name><name><surname>Zandasrar</surname><given-names>P.</given-names></name><name><surname>Hamishekar</surname><given-names>H.</given-names></name><etal/></person-group><article-title>The effect of penetration enhancers on drug delivery through skin: A QSAR study</article-title><source>J. Control. Release</source><year>2004</year><volume>99</volume><fpage>113</fpage><lpage>125</lpage><pub-id pub-id-type="pmid">15342185</pub-id></mixed-citation></ref><ref id="CR84"><label>84.</label><mixed-citation publication-type="journal"><person-group person-group-type="author"><name><surname>Geinoz</surname><given-names>S.</given-names></name><name><surname>Guy</surname><given-names>R. H.</given-names></name><name><surname>Testa</surname><given-names>B.</given-names></name><etal/></person-group><article-title>Quantitative structure&#x02013;permeation relationships (QSPeRs) to predict skin permeation: A critical evaluation</article-title><source>Pharm. Res.</source><year>2004</year><volume>21</volume><fpage>83</fpage><lpage>92</lpage><pub-id pub-id-type="pmid">14984261</pub-id></mixed-citation></ref><ref id="CR85"><label>85.</label><mixed-citation publication-type="journal"><person-group person-group-type="author"><name><surname>Kang</surname><given-names>L.</given-names></name><name><surname>Yap</surname><given-names>C. W.</given-names></name><name><surname>Lim</surname><given-names>P. F. C.</given-names></name><etal/></person-group><article-title>Formulation development of transdermal dosage forms: Quantitative structure&#x02013;activity relationship model for predicting activities of terpenes that enhance drug penetration through human skin</article-title><source>J. Control. Release</source><year>2007</year><volume>120</volume><fpage>211</fpage><lpage>219</lpage><pub-id pub-id-type="pmid">17582639</pub-id></mixed-citation></ref><ref id="CR86"><label>86.</label><mixed-citation publication-type="journal"><person-group person-group-type="author"><name><surname>Williams</surname><given-names>A. C.</given-names></name><name><surname>Barry</surname><given-names>B. W.</given-names></name></person-group><article-title>Penetration enhancers</article-title><source>Adv. Drug Del. Dev.</source><year>2004</year><volume>56</volume><fpage>603</fpage><lpage>618</lpage></mixed-citation></ref><ref id="CR87"><label>87.</label><mixed-citation publication-type="journal"><person-group person-group-type="author"><name><surname>Cal</surname><given-names>K.</given-names></name></person-group><article-title>How does the type of vehicle influence the in vitro skin absorption and elimination kinetics of terpenes?</article-title><source>Arch. Dermatol. Res.</source><year>2006</year><volume>297</volume><fpage>311</fpage><lpage>315</lpage><pub-id pub-id-type="pmid">16328342</pub-id></mixed-citation></ref><ref id="CR88"><label>88.</label><mixed-citation publication-type="journal"><person-group person-group-type="author"><name><surname>Fang</surname><given-names>J. Y.</given-names></name><name><surname>Tsai</surname><given-names>T. H.</given-names></name><name><surname>Lin</surname><given-names>Y. Y.</given-names></name><name><surname>Wong</surname><given-names>W. W.</given-names></name><name><surname>Wang</surname><given-names>M. N.</given-names></name><name><surname>Huang</surname><given-names>J. F.</given-names></name></person-group><article-title>Transdermal delivery of tea catechins and theophylline enhanced by terpenes: A mechanistic study</article-title><source>Biol. Pharm. Bull.</source><year>2007</year><volume>30</volume><fpage>343</fpage><lpage>349</lpage><pub-id pub-id-type="pmid">17268077</pub-id></mixed-citation></ref><ref id="CR89"><label>89.</label><mixed-citation publication-type="journal"><person-group person-group-type="author"><name><surname>Krishnaiah</surname><given-names>Y.</given-names></name><name><surname>Al-Saidan</surname><given-names>S.</given-names></name><name><surname>Chandrasekhar</surname><given-names>D.</given-names></name><name><surname>Satyanarayana</surname><given-names>V.</given-names></name></person-group><article-title>Controlled <italic>in vivo</italic> release of nicorandil from a carvone-based transdermal therapeutic system in human volunteers</article-title><source>Drug Del.</source><year>2006</year><volume>13</volume><fpage>69</fpage><lpage>77</lpage></mixed-citation></ref><ref id="CR90"><label>90.</label><mixed-citation publication-type="journal"><person-group person-group-type="author"><name><surname>Krishnaiah</surname><given-names>Y. S. R.</given-names></name><name><surname>Satyanarayana</surname><given-names>V.</given-names></name><name><surname>Bhaskar</surname><given-names>P.</given-names></name></person-group><article-title>Influence of limonene on the bioavailability of nicardipine hydrochloride from membrane-moderated transdermal therapeutic systems in human volunteers</article-title><source>Int. J. Pharm.</source><year>2002</year><volume>247</volume><fpage>91</fpage><lpage>102</lpage><pub-id pub-id-type="pmid">12429488</pub-id></mixed-citation></ref><ref id="CR91"><label>91.</label><mixed-citation publication-type="journal"><person-group person-group-type="author"><name><surname>Krishnaiah</surname><given-names>Y. S.</given-names></name><name><surname>Satyanarayana</surname><given-names>V.</given-names></name><name><surname>Karthikeyan</surname><given-names>R. S.</given-names></name></person-group><article-title>Penetration enhancing effect of menthol on the percutaneous flux of nicardipine hydrochloride through excised rat epidermis from hydroxypropyl cellulose gels</article-title><source>Pharm. Dev. Technol.</source><year>2002</year><volume>7</volume><fpage>305</fpage><lpage>315</lpage><pub-id pub-id-type="pmid">12229262</pub-id></mixed-citation></ref><ref id="CR92"><label>92.</label><mixed-citation publication-type="journal"><person-group person-group-type="author"><name><surname>Ventura</surname><given-names>P.</given-names></name><name><surname>Schiavi</surname><given-names>M.</given-names></name><name><surname>Serafini</surname><given-names>S.</given-names></name></person-group><article-title>The metabolism of <italic>trans</italic>-sobrerol in the rat</article-title><source>Xenobiotica</source><year>1983</year><volume>13</volume><fpage>139</fpage><lpage>146</lpage><pub-id pub-id-type="pmid">6613159</pub-id></mixed-citation></ref><ref id="CR93"><label>93.</label><mixed-citation publication-type="journal"><person-group person-group-type="author"><name><surname>Ventura</surname><given-names>P.</given-names></name><name><surname>Pellegata</surname><given-names>R.</given-names></name><name><surname>Schiavi</surname><given-names>M.</given-names></name><name><surname>Serafini</surname><given-names>S.</given-names></name></person-group><article-title>Biotransformation of <italic>trans</italic>-sobrerol. III. Metabolites of 8-hydroxycarvonacetone in the rat</article-title><source>Xenobiotica</source><year>1986</year><volume>16</volume><fpage>317</fpage><lpage>323</lpage><pub-id pub-id-type="pmid">3716453</pub-id></mixed-citation></ref><ref id="CR94"><label>94.</label><mixed-citation publication-type="journal"><person-group person-group-type="author"><name><surname>Diliberto</surname><given-names>J. J.</given-names></name><name><surname>Srinivas</surname><given-names>P.</given-names></name><name><surname>Overstreet</surname><given-names>O.</given-names></name><etal/></person-group><article-title>Metabolism of citral, an R,<italic>&#x000e2;</italic>-unsaturated aldehyde, in male F344 rats</article-title><source>Drug Metab. Dispos.</source><year>1990</year><volume>18</volume><fpage>866</fpage><lpage>875</lpage><pub-id pub-id-type="pmid">1981530</pub-id></mixed-citation></ref><ref id="CR95"><label>95.</label><mixed-citation publication-type="journal"><person-group person-group-type="author"><name><surname>Kouzi</surname><given-names>S. A.</given-names></name><name><surname>McChesney</surname><given-names>J. D.</given-names></name><name><surname>Walker</surname><given-names>L. A.</given-names></name></person-group><article-title>Identification of four bilinary metabolites of the diterpene sclareol in the laboratory rat</article-title><source>Xenobiotica</source><year>1993</year><volume>23</volume><fpage>621</fpage><lpage>632</lpage><pub-id pub-id-type="pmid">8212736</pub-id></mixed-citation></ref><ref id="CR96"><label>96.</label><mixed-citation publication-type="journal"><person-group person-group-type="author"><name><surname>Asakawa</surname><given-names>Y.</given-names></name><name><surname>Ishida</surname><given-names>T.</given-names></name><name><surname>Toyota</surname><given-names>M.</given-names></name><etal/></person-group><article-title>Terpenoid biotransformation in mammals IV. Biotransformation of (+)-longifolene, (&#x02212;)-caryophyllene, (&#x02212;)- caryophyllene oxide, (&#x02212;)-cyclocolorenone, (+)-nootkatone, (&#x02212;)-elemol, (&#x02212;)-abietic acid and (+)-dehydroabietic acid in rabbits</article-title><source>Xenobiotica</source><year>1986</year><volume>16</volume><fpage>753</fpage><lpage>767</lpage><pub-id pub-id-type="doi">10.3109/00498258609043566</pub-id><pub-id pub-id-type="pmid">3765656</pub-id></mixed-citation></ref><ref id="CR97"><label>97.</label><mixed-citation publication-type="journal"><person-group person-group-type="author"><name><surname>Ishida</surname><given-names>T.</given-names></name><name><surname>Toyota</surname><given-names>M.</given-names></name><name><surname>Asakawa</surname><given-names>Y.</given-names></name></person-group><article-title>Terpenoid biotransformation in mammals. V. Metabolism of (+)-citronellal, (+/&#x02212;)-7-hydroxycitronellal, citral, (&#x02212;)-perillaldehyde, (&#x02212;)-myrtenal, cuminaldehyde, thujone, and (+/&#x02212;)-carvone in rabbits</article-title><source>Xenobiotica</source><year>1989</year><volume>19</volume><fpage>843</fpage><lpage>855</lpage><pub-id pub-id-type="pmid">2815827</pub-id></mixed-citation></ref><ref id="CR98"><label>98.</label><mixed-citation publication-type="journal"><person-group person-group-type="author"><name><surname>Eriksson</surname><given-names>K. A.</given-names></name><name><surname>Levin</surname><given-names>J. O.</given-names></name></person-group><article-title>Identification of <italic>cis</italic>- and <italic>trans</italic>-verbenol in human urine after occupational exposure to terpenes</article-title><source>Int. Arch. Occup. Environ. Health</source><year>1990</year><volume>62</volume><fpage>379</fpage><lpage>383</lpage><pub-id pub-id-type="pmid">2228258</pub-id></mixed-citation></ref><ref id="CR99"><label>99.</label><mixed-citation publication-type="journal"><person-group person-group-type="author"><name><surname>K&#x000f6;ppel</surname><given-names>C.</given-names></name><name><surname>Tenczer</surname><given-names>J.</given-names></name><name><surname>T&#x000f6;nnesmann</surname><given-names>U.</given-names></name><etal/></person-group><article-title>Acute poisoning with pine oils metabolism of monoterpenes</article-title><source>Arch. Toxicol.</source><year>1981</year><volume>49</volume><fpage>73</fpage><lpage>78</lpage><pub-id pub-id-type="pmid">7325802</pub-id></mixed-citation></ref><ref id="CR100"><label>100.</label><mixed-citation publication-type="journal"><person-group person-group-type="author"><name><surname>Engel</surname><given-names>W.</given-names></name></person-group><article-title>In vivo studies on the metabolism of the monoterpenes <italic>S</italic>-(+)- and <italic>R</italic>-(&#x02212;)-carvone in humans using the metabolism of ingestion-correlated amounts (MICA) approach</article-title><source>J. Agric. Food Chem.</source><year>2001</year><volume>49</volume><fpage>4069</fpage><lpage>4075</lpage><pub-id pub-id-type="pmid">11513712</pub-id></mixed-citation></ref><ref id="CR101"><label>101.</label><mixed-citation publication-type="journal"><person-group person-group-type="author"><name><surname>Moorthy</surname><given-names>B.</given-names></name><name><surname>Madyashtha</surname><given-names>P.</given-names></name><name><surname>Madyastha</surname><given-names>K. M.</given-names></name></person-group><article-title>Metabolism of a monoterpene ketone, <italic>R</italic>-(+)-pulegonesa hepatotoxin in rat</article-title><source>Xenobiotica</source><year>1989</year><volume>19</volume><fpage>217</fpage><lpage>224</lpage><pub-id pub-id-type="pmid">2728495</pub-id></mixed-citation></ref><ref id="CR102"><label>102.</label><mixed-citation publication-type="journal"><person-group person-group-type="author"><name><surname>Madyastha</surname><given-names>K. M.</given-names></name><name><surname>Gaikwad</surname><given-names>N. W.</given-names></name></person-group><article-title>Metabolic fate of <italic>S</italic>-(&#x02212;)-pulegone in rat</article-title><source>Xenobiotica</source><year>1998</year><volume>28</volume><fpage>723</fpage><lpage>734</lpage><pub-id pub-id-type="pmid">9741951</pub-id></mixed-citation></ref><ref id="CR103"><label>103.</label><mixed-citation publication-type="journal"><person-group person-group-type="author"><name><surname>Madyastha</surname><given-names>K. M.</given-names></name><name><surname>Paul Raj</surname><given-names>C.</given-names></name></person-group><article-title>Studies on the metabolism of a monoterpene ketone, <italic>R</italic>-(+)-pulegonesa hepatotoxin in rat: Isolation and characterization of new metabolites</article-title><source>Xenobiotica</source><year>1993</year><volume>23</volume><fpage>509</fpage><lpage>518</lpage><pub-id pub-id-type="pmid">8342298</pub-id></mixed-citation></ref><ref id="CR104"><label>104.</label><mixed-citation publication-type="journal"><person-group person-group-type="author"><name><surname>Madyastha</surname><given-names>P.</given-names></name><name><surname>Moorthy</surname><given-names>B.</given-names></name><name><surname>Vaidyanathan</surname><given-names>C. S.</given-names></name><etal/></person-group><article-title><italic>In vivo</italic> and <italic>in vitro</italic> destruction of rat liver cytochrome <italic>P</italic>-450 by a monoterpene ketone, pulegone</article-title><source>Biochem. Biophys. Res. Commun.</source><year>1985</year><volume>128</volume><fpage>921</fpage><lpage>927</lpage><pub-id pub-id-type="doi">10.1016/0006-291X(85)90134-2</pub-id><pub-id pub-id-type="pmid">3994727</pub-id></mixed-citation></ref><ref id="CR105"><label>105.</label><mixed-citation publication-type="journal"><person-group person-group-type="author"><name><surname>Chen</surname><given-names>L. J.</given-names></name><name><surname>Lebetkin</surname><given-names>E. H.</given-names></name><name><surname>Burka</surname><given-names>L. T.</given-names></name></person-group><article-title>Metabolism of (<italic>R</italic>)-(+)-pulegone in F344 rats</article-title><source>Drug Metab. Dispos.</source><year>2001</year><volume>29</volume><fpage>1567</fpage><lpage>1577</lpage><pub-id pub-id-type="pmid">11717176</pub-id></mixed-citation></ref><ref id="CR106"><label>106.</label><mixed-citation publication-type="journal"><person-group person-group-type="author"><name><surname>Madyastha</surname><given-names>K. M.</given-names></name><name><surname>Paul Raj</surname><given-names>C.</given-names></name></person-group><article-title>Biotransformations of <italic>R</italic>-(+)- pulegone and menthofuran <italic>in vitro</italic>: Chemical basis for toxicity</article-title><source>Biochem. Biophys. Res. Commun.</source><year>1990</year><volume>173</volume><fpage>1086</fpage><lpage>1092</lpage><pub-id pub-id-type="pmid">2268314</pub-id></mixed-citation></ref><ref id="CR107"><label>107.</label><mixed-citation publication-type="journal"><person-group person-group-type="author"><name><surname>Madyastha</surname><given-names>K. M.</given-names></name><name><surname>Moorthy</surname><given-names>B.</given-names></name></person-group><article-title>Pulegone mediated hepatotoxicity: Evidence for covalent binding of <italic>R</italic>-(+)-[14C]pulegone to microsomal proteins <italic>in vitro</italic></article-title><source>Chem. Biol. Interact.</source><year>1989</year><volume>72</volume><fpage>325</fpage><lpage>333</lpage><pub-id pub-id-type="pmid">2691105</pub-id></mixed-citation></ref><ref id="CR108"><label>108.</label><mixed-citation publication-type="journal"><person-group person-group-type="author"><name><surname>Khojasteh-Bakht</surname><given-names>S. C.</given-names></name><name><surname>Chen</surname><given-names>W.</given-names></name><name><surname>Koenigs</surname><given-names>L. L.</given-names></name><etal/></person-group><article-title>Metabolism of (<italic>R</italic>)-(+)-pulegone and (<italic>R</italic>)-(+)- menthofuran by human liver cytochrome <italic>P</italic>-450s: Evidence for formation of a furan epoxide</article-title><source>Drug Metab. Dispos.</source><year>1999</year><volume>27</volume><fpage>574</fpage><lpage>580</lpage><pub-id pub-id-type="pmid">10220485</pub-id></mixed-citation></ref><ref id="CR109"><label>109.</label><mixed-citation publication-type="journal"><person-group person-group-type="author"><name><surname>Engel</surname><given-names>W.</given-names></name></person-group><article-title><italic>In vivo</italic> studies on the metabolism of the monoterpene pulegone in humans using the metabolism of ingestion-correlated amounts (MICA) approach: Explanation for the toxicity differences between (<italic>S</italic>)-(&#x02212;)- and (<italic>R</italic>)-(+)-pulegone</article-title><source>J. Agric. Food Chem.</source><year>2003</year><volume>51</volume><fpage>6589</fpage><lpage>6597</lpage><pub-id pub-id-type="pmid">14558782</pub-id></mixed-citation></ref><ref id="CR110"><label>110.</label><mixed-citation publication-type="journal"><person-group person-group-type="author"><name><surname>Gordon</surname><given-names>W. P.</given-names></name><name><surname>Huitric</surname><given-names>A. C.</given-names></name><name><surname>Seth</surname><given-names>C. L.</given-names></name><etal/></person-group><article-title>The metabolism of the abortifacient terpene, (<italic>R</italic>)-(+)-pulegone, to a proximate toxin, menthofuran</article-title><source>Drug Metab. Dispos.</source><year>1987</year><volume>15</volume><fpage>589</fpage><lpage>594</lpage><pub-id pub-id-type="pmid">2891472</pub-id></mixed-citation></ref><ref id="CR111"><label>111.</label><mixed-citation publication-type="journal"><person-group person-group-type="author"><name><surname>Madyastha</surname><given-names>K. M.</given-names></name><name><surname>Paul Raj</surname><given-names>C.</given-names></name></person-group><article-title>Evidence for the formation of a known toxin, <italic>p</italic>-cresol from menthofuran</article-title><source>Biochem. BiophysRes. Commun.</source><year>1991</year><volume>177</volume><fpage>440</fpage><lpage>446</lpage></mixed-citation></ref></ref-list></back></article>